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SUMMARY

Chemical ionization mass spectrometry has been used for the rapid and
quantitative analysis of amino acids, fatty acid, free and bound cholesterol and estriol in biological fluids.

The analysis depends on the ex-

traction of a particular class of metabolites from the sample with an
organic solvent followed by direct chemical ionization mass spectrometry
on the extract without prior chromatographic separation.

Quantitation has

been achieved by the addition of stable isotopically labelled internal
standards and mass spectral peak height measurement of the labelled and
unlabelled protonated molecular ions.

The method permits the determination

of metabolites of interest down to a level of 25 ng, whilst still maintaining a signal/noise ratio better than 10:1.

The analysis is reproducible

with a standard deviation of less than 5%.
The procedure has been applied to the analysis of microsamples of
blood spotted on filter paper, as well as other biological fluids.

For

the analysis of blood amino acids, an 80% alcoholic extract is used which
is treated with acetic anhydride-methanol.

This converts all the amino

acid to N-acetyl methyl esters which have unique protonated molecular ion
peaks with the exception of leucine and isoleucine which can not be distinguished.

The new amino acid analysis has been evaluated against the

Guthrie microbiological inhibition test and against ion-exchange
chromatography.
In a similar fashion but by chloroform-methanol extraction of the
sample without derivatization, free fatty acid and cholesterol levels have
been quantitized and the results have been compared with thin-layer
chromatography, gas chromatography and enz3nniatic methods.

The new analysis

has also been applied to a number of clinical situations such as the
diagnosis of genetic defects and the testing for heterozygosity.

Ill

Finally the procedure has been used to study metabolic defects by
examining blood samples from patients who had been fed stable isotopically
labelled amino acids.

Preliminary experiments on the analysis of protein

hydrolysates and of estriol in pregnancy urine, suggest that the method
could also be applied for these purposes.

Some of the results obtained in

this study have been published in the following papers:
(1)

"A rapid and quantitative gas chromatographic determination of

glutamine in the presence of glutamic acid", Anal. Letters, 9:605
(2)

"Rapid and quantitative blood analysis for free fatty acids by

chemical ionization mass spectrometry", Anal. Letters, 9:1075
(3)

(1976).

(1976).

"Rapid and quantitative blood amino acid analysis by chemical

ionization mass spectrometry", Biomed. Mass Spectrometry,

(Feb. 1977).

INTRODUCTION

During the past 30 years the value of clinical chemistry to health
care has been increasingly recognized.

However, during the last decade the

cost of clinical services has also increased enormously, and this has been
countered effectively by instrumental automation.

For example the clinical

auto-analyzer today can complete 20 or more discrete analyses in a 3 ml
sample at the rate of 40-80 samples per hour.

Unfortunately, the 'auto-

analyzer' concept can not be applied to a number of important clinical
areas which require the quantitative determination of a group of related
metabolites such as the amino acids or fatty acids, etc.

Clinical analysis

of amino acids and fatty acids, beyond the simple non-specific chemical
tests, are rather time consuming, require relatively large samples and are
consequently expensive.

The present procedures generally involve extensive

sample handling, purification and/or derivatization and time-consuming
chromatographic separation.

This complexity of operation requires skilled

clinical personnel which adds to the cost of the analysis.
The following summarizes the more important clinical developments in
the analysis of amino acids and fatty acids over the past 25 years.

During

this period, ion-exchange chromatography and gas chromatography have been
extensively developed and have remained the major analytical techniques for
this purpose to this day.
The basic concept of the amino acid analyzer was developed by Moore
and Stein in 1951^1).

The original amino acid analyzer employed two ion

exchange columns to effect the separation of the neutral, acidic and basic
amino acids.

This was followed by the collection of the eluate containing

the isolated amino acids which were subsequently quantitatively analyzed
for amino acid content.

This basic device was modified so as to determine

automatically the amino acid content of the eluate as it emerged from the
ion exchange column(2).

in this set up, the emerging column eluate is

mixed with ninhydrin reagent and the solution enters a mixing coil
immersed in a boiling water bath in which the reaction with ninhydrin is
completed.

The reaction product of ninhydrin with amino acids is a blue

compound which absorbs light at 570 nm.

The absorbance of the eluate

emerging from the boiling water bath is constantly monitored and recorded
by a chart recorder.

The imino acids, proline and hydroxyproline, form a

yellow compound upon reaction with ninhydrin, which necessitates the incorporation of a second channel to monitor the eluate at 440 nm in order
to quantitate these amino acids.
In 1960, Piez and Morris^^^ developed a simplified scheme for the
automatic analysis of amino acids.

It employed a single ion exchange

column from which the amino acids were eluted with a continuous gradient
buffer.

The single column methodology was critically examined by Hamilton
(4)

in 1963

.

The instrument was then used for the quantitative determina-

tion of the free amino acids in 0.1 ml of venous blood plasma of the newborn child^^\

The single ion exchange column possessed the advantage

that only one application of the sample was required for a complete
analysis of protein amino acids.

This of course was important if only a

limited amount of physiological fluid was available.

The chief drawback

of the single column system was the change in baseline which appeared with
the high ion strength buffers in a stepwise system.

This baseline shift

was due to the presence of ammonium ions which contaminated the early
buffers.
These first generation analyzers required at least 24 hours per
analysis and more than 100 nanomoles of each amino acid was needed for a
quantitative analysis.

Over the last ten years, a great deal of effort

has been expended to increase the sensitivity and speed of the ion exchange
technique.

Kirsten and Kirsten^^^ assembled a micro-amino acid analyzer

based on anion exchange resins in capillary c o l u m n s T h i s

instrument

was capable of quantitatively resolving as little as two picomoles of an
amino acid.

A commercial microanalyzer using this principle was later de-

veloped, and this instrument was used for a number of clinical applications such as the study of inborn errors of amino acid metabolism^^^.
However, this commercial instrument did not completely resolve all the
(9)
amino acid in one step.

Gressner

later modified this microanalyzer by

changing the buffer pH, which resulted in the resolution of all common
amino acids of biological interest.

By using four Teflon capillary

columns, which allowed regeneration of two of the columns during a run, a
greater number of analysis could be run each day.

This microanalyzer had

a precision of + 3.6% for the neutral and acidic amino acids and + 4 . 3 % for
the basic amino acids.

The precision of proline was poor at + 8.4% and

recovery of amino acids was about 90%.

This microanalyzer was capable to

quantitate a mixture containing 150 picomoles of each amino acid, with an
analysis time of 12 hours.
In the past four years, some modifications to the ninhydrin detection
system of the amino acids have been introduced.

This new approach offers

higher sensitivity, and thus widens the scope of application for amino acid
analysis.

The new reagent, fluorescamine^^^\ forms a fluorescent deriva-

tive with the amino acids and it was first used to determine the phenylalanine level in

Unfortunately, fluorescamine has only a

limited solubility in aqueous buffers and thus it must be dissolved in an
organic solvent (usually acetone) first, before it can be metered to the
column eluate.

Recently a second fluorimetric detection method using
(12)

phtalaldehyde has been developed for use in the amino acid analyzer
This reagent is more specific for amino acids than fluorescamine because
the reagent does not react with proteins or peptides.

These two reagents

are already in use in some commercially available amino acid analyzer
(13)
systems

.

The major disadvantage of both detection methods is the in-

ability to form fluorescent derivatives with the two imino amino acids
proline and hydroxyproline, and a modification of the detection system is
required to overcome this difficulty.
In order to shorten the analysis time, Ertingshausen and Adler^^^^
later increased the working pressure of the ion exchange separation processes to 700-800 psi on

a Technicon Multiple Amino Acid Analyzer TSM,

and they were able to separate the amino acids in 6 hours with a 2-column
system.

Two years later, Benson^^^^reported a 6-hour, high pressure,

single column analysis for amino acids.

Recently, a high pressure

commercial system capable of operating at 300 psi pressure has been
developed by Durrum Instruments (U.S.A.), in which a stainless steel, small
bore (0.176 x 48 cm) column containing 8 micron resin beads is used.

This

machine will carry out a complete amino acid analysis in about 3-5 hours
and the sensitivity of the system is sufficiently high to allow for the
analyses of nanomole levels of amino acids in biological fluids.
Despite these dramatic improvements in the instrumentation, the
complexity

of the operation and the long analysis time have made ion

exchange chromatography of doubtful value for routine application in a
clinical chemistry.
Other methods for the analysis of amino acids in biological fluids
such as electrophoresis^^^^;

thin-layer^^^'^^^ and gas-liquid

chromatography (GLC) have also been used clinically for the detection of
amino acid abnormalities, however, with the exception of GLC, they have
not been applied successfully to a clinically useful quantitative
technique.

In the last two decades, gas-liquid chromatography (GLC)^^^^ has
attained great prominence in analytical chemistry.

The inherent speed and

sensitivity of the technique has focused attention on its possible use in
clinical situations.

The first application of GLC for amino acid was

(21)
reported in 1956

.

Since then the analytical applications of this

technique to amino acid analysis has been advanced through extensive
studies involving numerous derivatization methods, column technology and
u
.
u..
.
(22,23,24,25,26) ^
^
. .. i
chromatographic separation systems
. Among the most widely
adopted derivatives for amino acids analysis are the N-trifluoroacetyl
n-butyl esters

(27 28 29)
(25)
* '
, the N-acetyl n-propyl
and the trimethylsilyl

(30 31)
derivatives

*

.

Despite the many attempts, the GLC of amino acids is

still not entirely satisfactory for clinical work as the derivatization
processes are time consuming, involve complex chemistry, require multiple
sample manipulations and most of the derivatives are hydrolytically unstable.

In addition all steps require careful attention to detail, for

example, some derivatives are very volatile and are readily lost during
concentration of the sample whilst other derivatives are not sufficiently
volatile for chromatography on polar columns.

The best solution, namely,

the GLC separation of N-trifluoroacetyl n-butyl esters takes about one hour
using a two column methodology and 50 nanograms of each amino acid are
needed, as two derivatization steps—esterification and acetylation—are
required.
Prior to derivatization, time consuming clean-up procedures involving many steps are also required in the specific case of analyzing biological fluid.

The serum and urinary amino acids, for example, are usually

isolated by ion-exchange chromatographic methods and are retained on the
ion exchange resin, while the substances which interfere with the GLC
analysis pass through the ion exchange column.

The amino acids are then

eluated from the column with ammonia, derivatized to their N-trifluoroacetyl derivatives, and analyzed by GLC.

The ion-exchange clean-up steps

require at least 30 minutes and additional time is needed to pack and
prepare the resin column.

In actual practice, about 0.1 ml of a serum

sample is required and the final ion-exhcange eluate is about 3-4 ml.
Since the eluate has to be collected and evaporated to dryness, a further
20-30 minutes is required before the sample can be derivatized for GLC.
It is obvious that this is not entirely suitable for routine clinical work.
During the last five years, research efforts have been directed
toward increased speed and simplification of the GLC procedure for the
quantitative analysis of amino acids.

One column methodology and simple
(32,33,34,35,36)

derivatization procedures have been tried for these purposes

.

but all attempts to further simplify the derivatization process have been
unsuccessful.

On the other hand, time consuming clean-up procedure can be

eliminated if a nitrogen detector is used for GLC, as such a detector only
responds to organic nitrogen compounds, and thus a quantitative ,(37,38,39)
measurement of the amino acids is more readily made on the chart record
A 20 jil sample of plasma is sufficient for a quantitative amino acid
.
. (40)
analysis
The advent of amino acid analysis by means of GLC combined with mass
fragmentography has also eliminated the need for complete chromatographic
resolution of the amino acid derivatives.

The analytical system required

consists of a gas chromatograph interfaced with a mass spectrometer which
is used as a specific ion detector.

Summons et al.^"^^^ have reported the

determination of 12 amino acids in biological fluids by GLC-mass fragmentography.

A quantitative amino acid determination could be made on

50 yl of plasma or urine and as deuterated amino acid were used as internal
standards complete derivatization of the sample was not required.

Abramson

and co-workers^^^^ demonstrated an assay of plasma amino acids by a
simpler approach.

In this method, the retention time as well as char-

acteristic ion fragments of the compounds in the mass spectra were used to
identify and quantitize the amino acids.

More recently, tissue levels of

glutamic acid and y-amino butyric acid were also quantitatively determined
by GLC-mass f r a g m e n t o g r a p h y T h e

references cited above clearly in-

dicate that the GLC-MS analysis of amino acids is a valuable analytical
technique for the quantitative estimation of small amounts of amino acids
in biological fluids, but the complexity of the instrumentation makes such
a system quite unsuitable for routine clinical work.
The use of ion-exchange chromatography for the analysis of fatty acids
and other lipid metabolites, e.g., sterols, has not been particularly
successful because most of these compounds are only sparingly soluble in
an aqueous media.

Thus, most published analytical methods for these

metabolites have involved chromatographic separations in a non-aqueous
media.

Paper, thin layer and gas chromatography have been used for this

purpose, but of these only GLC has been applied for the quantitative
analysis of fatty acids and steroids.
Gas liquid chromatography is already widely used for analysis of
fatty a c i d s a n d

the technique is more frequently used in the clinical

laboratory for the determination of free fatty acid (FFA) levels in
plasma.
Individual FFA can be determined by GLC as their methyl ester
trimethylsilyl e s t e r d e r i v a t i v e s .

or

Depending on the origin of the

sample the GLC method often requires lengthy sample extraction and other
chromatographic separations prior to the derivatization step.

For example,

Ko and Royer^^^^ have recently reported a procedure for individual FFA in
plasma, in which the FFA were extracted into an organic phase after which

they were purified with silicic acid prior to derivatization.

The

derivatization of fatty acids can sometimes be avoided for plasma
(48 49)
analysis

'

, but again the required purification steps are still quite

time consuming.
Direct mass spectrometry has been used for a qualitative analysis of
pure amino a c i d s a n d

fatty a c i d s S o m e

attempts have also been

made to qualitatively analyze for FFA content of vegetable oil hydrolysates.

To date no quantitative determination of FFA or amino acids by

mass spectrometry without prior separation has been reported.
We have now developed a novel, direct mass spectrometric amino acid
analysis and have applied it to distinguish abnormals from normals in a
genetically oriented screening program.

Since chromatographic separation

is not required, a complete quantitative analysis is possible in a short
time (about 15 min.).

The analysis has also been applied to estimate

blood fatty acids and cholesterol.

It has also been shown that other

metabolites can be analyzed by this route.

RESULTS AND DISCUSSION

One of the time consuming steps often associated with the quantitative
analysis of biological fluids is the sample "clean up" which is often required prior to analysis.

For example blood, serum or amniotic fluid have

to be deproteinized and, in some cases, the amino acids or fatty acids have
to be extracted and derivatized prior to analysis.

All these manipulations

significantly add to the analysis time and make the conventional systems
unsuitable for routine clinical applications.

An alternative approach to

the handling of blood and serum samples makes use of dried blood or serum
specimens spotted on filter paper from which the amino acids can be eluted
for TLC or used directly for bacterial inhibition a s s a y s ^ ^ ^ ' ' U p

to

now, the quantitative determination of amino acids from such a small blood
sample (ca 5-10 yl) has been rather difficult and none of the published
methods have been entirely satisfactory for routine clinical use.
Since direct mass spectrometry has sufficient sensitivity to cope with
such small sample sizes it was decided to use the dried filter paper disc
method for this work.

We also appreciated the fact that most genetically

oriented amino acid screening p r o g r a m s

rely on a definite quantitative

follow-up test to clearly distinguish an abnormal from a normal individual
and our new technique was to be suitable for this purpose.

Preliminary ex-

periments with dried filter paper blood spots showed that an 80% ethanol
treatment is sufficient to extract all the free amino acids from the paper.
During this extraction the blood proteins are denatured and are retained by
the filter paper.

After removal of the filter disc, followed by evaporation

of the solvent, the dried residue is in a suitable form for derivatization
and mass spectrometry.
Free amino acids have already been analyzed by direct mass spectrometry
without prior derivatization.

In general, however, the high temperatures

required for volatilization lead to dehydration, decarboxylation and de-

amination of some of the amino acids and thus the mass spectra show a low
abundance of the molecular ions (less than 1% in some cases)
Our experiments on underivatized amino acids confirmed these observations
and we found it impossible to use this approach for the quantitative
analysis of amino acids.
There are comprehensive reviews about the preparation of volatile
derivative of amino a c i d s ^ ^ ^ ' ^ ^ ' ' ^ ^ ' T h e s e have been aimed at the
gas-liquid chromatographic separation of amino acids and a wide range of
suitable derivatives have been developed for this purpose.

However, most

of the proposed methods are very time-consuming and are also difficult to
apply to all the 20 protein amino acids. Whilst N-trifluoroacetyl n-butyl
esters of amino acids are the most suitable for GLC analysis, we found them
rather difficult to prepare as the procedure involves a number of steps.
In addition the derivatives were unstable to traces of water and were too
volatile for direct mass spectrometric analysis.
The advantages of using a simple pyrolytic derivatization approach,
for example, the conversion of a tetraalkyl ammonium salt of an amino acid
to its methyl ester in the solid probe of the MS, has been used by Halpern
et al. and the method has been applied for the sequencing of peptides by
direct mass s p e c t r o m e t r y ^ ^ ^ T h u s , our earlier attempts were directed
to the derivatization of amino acids using tetramethyl (or trimethylphenyl)
(62 63)
ammonium hydroxide in the presence of an aldehyde or ketone

'

.

For

example, the amino acid phenylalanine (I) could be converted to its neopentylidene or acetylacetonyl trimethylanilinium salt by the above procedure.

Subsequent pyrolysis of the salt in the solid probe tip of the mass

spectrometer yielded the corresponding neopentylidene methyl ester derivative (II) or acetylacetonyl methyl ester derivative (III) which were
sufficiently volatile for mass spectroscopic analysis.

R-CH-COOH
I
NH2

R-CH-C00CH3
I
N
II
CH
I
C(CH3)3

(I)

(II)

R-CH-C00CH3
•
NH
»
CH3-C = CH-CO-CH3

(III)

The chemical procedure of this method is relatively simple as the derivatization involves only one step.

However, it takes several hours for

enamine formation to be complete and this is a serious disadvantage for
any clinical application.
In later experiments, it was found that acetic anhydride could be
used in the pyrolytic derivatization procedure instead of the ketones and
N-acetyl derivatives could be prepared within minutes at room temperature.
This modification was found to be suitable for all amino acids and could
be carried out on a micro scale.

Shortly afterwards we established, by

using different alcohols instead of methanol and different quaternary
bases such as tetraethyl ammonium hydroxide instead of tetramethyl ammonium
hydroxide, that acetic anhydride-methanol alone was responsible for the
methylation of the acidic functions and thus the addition of the quaternary
base was found to be unnecessary and was discontinued.
Our amino acid procedure now consisted of the derivatization of the
amino acids with methanol and acetic anhydride at 100° C for 5 minutes.
One of the advantages of this method is that glutamine and asparagine are
stable during the derivatization step and can be analyzed as their N-acetyl
methyl ester derivatives.

This seems to be one of the few methods avail-

able to estimate glutamine and asparagine without prior hydrolysis to
glutamic and aspartic acids.

We have already exploited this reaction by

developing a suitable GLC analysis by this route for glutamine and

asparagine^^^).
Preliminary studies on the direct mass spectrometric analysis of
N-acetyl phenylalanine methyl ester indicated that the technique of
electron impact (EI) mass spectrometry might be useful for the analysis of
one or several amino acids in biological samples.

The EI mass spectrum of

N-acetyl phenylalanine methyl ester yielded a molecular ion (M^) at m/e
221 and a characteristic amine fragment ion (M-COOCH3) at m/e 162.

Since

the (M+) ion intensity was less than 5% of the amine fragment intensity,
the ion at m/e 162 was used for our initial experiments.

For this purpose,

a fixed amount of deuterated phenylalanine (Phe-D^, 50 n mole) was added
to the known amounts of phenylalanine (0-100 n mole) and the mixture was
evaporated to dryness, derivatized and analyzed by direct EI mass spectrometry.

The ion peak height of phenylalanine (m/e 162) and of phenyl-

alanine-D5 (m/e 167) was measured and averaged, and the ratio of
phenylalanine/phenylalanine-D^ was obtained for each phenylalanine level
used.

Graphical analysis of the calibration data confirmed the linearity

of the assay.

The technique was next employed with plasma samples

phenylketonuric patients.

In practice, plasma (50 pl) was first de-

proteinized with ethanol (80%) following the addition of appropriate
amount of phenylalanine-D3 (12.5 n mole) and then the mixture was centrifuged and the supernatant was transferred to the reaction vial for
derivatization and mass spectrometry (Fig. 1).

Whilst this approach is

highly suitable for the analysis of individual amino acid in blood or
urine, it is difficult to establish interference

free characteristic ions

for all the amino acids known to be present in biological fluids.

Thus,

it seemed pretty obvious that milder mass spectrometric fragmentation
methods would be more suitable for this type of analysis and it was
decided to use chemical ionization (CI) mass spectrometry for this purpose
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The A EI mass spectra of N-acetyl methyl esters of phenylalanine and phenylalanine-D5 obtained from phenylketonuria plasma (A änd B) and normal plasma (C).

Chemical ionization mass spectrometry (CI-MS) was first reported by
Munson and Field in 1966(65) and has since been used by many investigators
as an analytical too 1(66)..
Compared "with the complex fragmentation
patterns that result from electron impact ionization, the mass spectra
produced by CI contain very few ions.

For each compound there is generally

a high intensity protonated molecular ion (MH."^) and at best only low intensities fragment ions.

The method is thus more suitable for the

analysis of mixtures, and the amount of each component can be readily
estimated from its molecular ion intensity.
CI mass spectra are generated by positively charged reagent gas ions
(RH+) which produce protonated molecular ions (MH"^) by collision in the
ion source of the mass spectrometer.

If isobutane is used, the t-butonium

ion (t-C4H9+) which are formed, will induce a proton transfer to other
molecules in the ion source.

Since the t-C4H^ will give the least exo-

thermic proton transfer reaction^^^), the resulting mass spectrum will
display the least amount of fragmentation.

The reaction of t-C4H9+ with

the sample in the CI source is shown in Fig. 2.

i-C4Hio +

^

t-C4H9'^

M + t-C4H9+

h

(MH+) + t-C4H8

(MH+)
Fig. 2.

^

M3_+ + M2+

Reactions in the chemical ionization source.

The energy transfer in this process is very much less than in electron
impact, and thus less energy is transferred to molecular ion species and
less fragmentation will result.

Fewer fragment ions mean that quantita-

tively most of the molecule is present as a single ion species and thus the
detectability is greatly increased.

The published CI mass spectra of free amino acids^^^), with methane
as the reactant gas, show the protonated molecular ions of each corresponding amino acids and single fragmentation patterns, namely, (MH"^) - H2O,
(MH+) - COOH^, (MH+) - NH^, etc.

These fragmentation patterns can be

rationalized as arising from decomposition of the molecule protonated at
several sites.

As is clear from these examples, CI-MS should be suitable

for the analysis of amino acid mixtures.
Whilst previous workers used methane gas for this purpose, we decided
to use isobutane as this is known to lead to even less fragmentation.
The CI (isobutane) mass spectra of N-acetyl amino acid methyl esters exhibited intense protonated molecular ions peaks and unique m/e values were
obtained for all amino acids with the exception of leucine and isoleucine
which yield the same protonated molecular ion (Table 1).
Of the common protein amino acids, glycine, alanine, serine, proline,
valine, threonine, leucine and isoleucine, methionine, phenylalanine,
histidine and tryptophan were all converted by acetic anhydride-methanol
to their corresponding mono-acetyl methyl esters.

Aspartic and glutamic

acids were converted to mono-acetyl di-methyl esters, and asparagine and
glutamine were in the form of an acetyl mono-methyl ester.

Cysteine,

lysine, tyrosine, arginine and cystine were present as di-acetyl methyl
ester derivatives.

Arginine did not yield a protonated molecular ion at

m/e 273 but instead intense peaks at m/e 157 (Fig. 3) and m/e 199 were
present.

The identity of these diagnostic peaks at m/e 157 and m/e 199

were confirmed by two follow-up experiments using (a) methanol and acetic
anhydride-D^, and (b) methanol-D4 and acetic anhydride as derivatizing
reagents, respectively.
The results of the first experiment showed that the peak at m/e 157
and at m/e 199 were shifted to m/e 160 and m/e 202, respectively.

Whilst

Table 1.

Amino Acid

Mass spectral data for N-acetyl amino ac id methyl esters

[M+1]"^

Amino Acid

Other

[M+1]"^

Diagnostic Peak

Glycine

132

Methionine

206

Alanine

146

Histidine

212

Serine

162

Glutamic acid

218

Proline

172

Cysteine

Valine

174

Phenylalanine

222

Threonine

176

Lysine^

245

Leucine

188

Tryptophan

261

Isoleucine

188

Tyrosine

Asparagine

189

Arginine^

Glutamine

203

Cystine

Aspartic acid

204

c

c

220

280
-

157^

-

176,178''

c

^[NH^ (CH^) ^-CHCNHCOCH^) CO]"^
^[S-CH2-CH(NHC0CH^)C00CH^]"^ and [HS-CH^-CHCNHCOCH^) COOCH^]"^
Q

Diacetyl derivative

in the second experiment, the intense peaks remained at m/e 157 and
m/e 199.
NH

Fig. 3.

157
H
-N-CH2-CH2-CH2-CH-CO f 0-CH3

Fragmentation of arginine molecule.

The spectrum of N,N di-acetyl cystine methyl esters exhibit two
characteristic peaks, e.g., m/e 176 and m/e 1 7 8 , which are derived from
the breakage of the di-sulfide ( s — s ) bond followed by proton loss or
gain(68).
These results demonstrated that the N-acetyl amino acid methyl
esters are suitable derivatives for direct C I mass spectrometry.

Our next

step was to establish whether a suitable quantitative analysis could be
developed.

The use of stable isotopically labelled standards for quanti-

tative C I mass spectrometric

analysis has already been e s t a b l i s h e d C ^ ^ , 7 0 ,

and thus we decided to use a similar approach for our problem.

Stable

isotope labelled amino acids are commercially available and some of them
were obtained and some were prepared by published methods.
In our first experiments, standard solutions of phenylalanine,
tyrosine, valine, glycine, aspartic acid and glutamic acid and their corresponding internal standard phenylalanine-D3, tyrosine-D2, valine-D^,
glycine-D2 or glycine-l^N, aspartic acid-l^N and glutamic acid-15N were
analyzed individually by direct CI mass spectrometry.

Later, a series of

amino acid mixtures and a fixed amount of the isotopically labelled amino
acids were used for quantitative calibration.

Calibration curves for

these selected amino acids were then determined by comparing the protonated
molecular ion peak height of a concentration range of unlabelled amino
acids with that of the appropriate isotopically labelled amino acid.

This

was done by a manual method in which 5 M.S. scans were recorded on U.V.
sensitive chart paper and the mean peak height ratio were compiled
(Fig. 4).

The slopes of the calibration lines were then used to calculate

the calibration factors which correct the results for the chemical and
isotopic purity of the internal standards.

If ^^N amino acids are used as

internal standard, correction should be made for the natural abundance of
13
C (1.08%) and D (0.016%) isotopes, as the internal standard signal will
be enhanced by these contributions of the unlabelled amino acid.

In

practice, we have found that if calibration and sample measurements are in
the same concentration range correction is not necessary.

This has been

done in experiments using ^^N-glycine, ^^N-leucine, ^^N-aspartic acid, and
^^N-glutamic acid.

A similar adjustment is also necessary if methionine

(m/e 206) is analyzed for in the presence of ^^N-aspartic acid (m/e 205).
More recently we have also used a computer to record spectral data and to
calculate the mean value and standard deviation.

In this mode we usually

recorded ten or more measurements for each analysis (Figs. 5 and 6).

The

technique was then applied to the analysis of a commercially available
amino acid mixture containing 1 n mole/ul of each amino acid.

The results

shown in Table 2 are the means and standard deviations obtained from four
separate analyses and are expressed in n mole per ]il.
standard deviations were less than 2% of the mean.

Ii^ ^ H cases, the

This compares
favorably
(A-X A2 A"3)

with GC-MS mass fragmentographic analyses currently in use

'

*

• Under

routine operating conditions, 25 nanogram of an amino acid is sufficient for
a quantitative analysis.

The linearity of the assay was further confirmed

by repeating the calibrations on artificially prepared blood spot amino acid

Phe
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Calibration curves obtained from an amino acid mixture
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Table 2.

Amino acid analysis by chemical ionization
mass spectrometry

Amino Acid

Amino Acid Mixture (1 n mole/yl)
Mean^ + S.E.M.^

Gly

1.,04

0.,02

Val

1.,00

0.,01

Asp

1.,06

0..02

Glu

1..04

0..02

Phe

0..96

0..01

Tyr

1,.03

0,.02

Average of four analyses
^S.E.M. = Standard Error of Mean

solutions (Figs. 7 and 8).

The experiments were carried out by using

samples of whole blood to which additional phenylalanine, glycine or valine
respectively had been added to produce amino acid concentration ranges of
0-15 nanomole.

To determine recoveries of amino acids from the blood

spot samples, we used blood spots (5 ]il) supplemented with amino acid
standards (5 n mole), and extracted, derivatized, and analyzed the samples
by CI-MS.

The increase or decrease^in peak height ratios (unlabelled to

labelled) of the blood amino acid were compared to the peak height ratios
obtained from a control experiment using unspiked blood spots to which
amino acids (5 n mole) were added at the extraction stage of the analysis.
The results are given in Table 3.

The recoveries were close to 100% with

a coefficient of variation of 2-3%.
The next step was to apply this new microanalytical method to the
analysis of small samples of blood from a genetic screening program.

This

was most conveniently done by using blood samples which has been spotted
on filter paper.

For the analysis, we used a punch (4 mm diameter) which

contains 5.5 yl blood and the blood amino acids were extracted with 80%
ethanol containing the appropriate labelled amino acids.

The mass spectra

were then recorded and the concentration of the amino acids in the blood
were calculated.
Fig. 9 shows the mass spectral profile obtained from a normal control
and from a patient suffering from phenylketonuria (PKU).

These spectra

were compiled by taking five mass spectral scans and manually measuring
the peak heights of the Mh"'" ions of phenylalanine-D^ (m/e 222) and
phenylalanine-D^ (m/e 227) for each scan.

The peak height ratios (Phe-D^

vs. Phe-D^) were then calculated and the average value was used for the
final calculation of amino acid concentration.

In this way we calculated

the Phe value (Fig. 9) in the control sample to be 1.9 mg % and the Phe

o
Qi
LD

C
UJ
Q_

PHE/PHE - D5 (MOLAR RATIO)
Fig. 7. Calibration curve for the quantitative determination of phenylalanine.
Whole blood was supplemented with phenylalanine to produce concentrations of 0 to 15 n mole per 5 \ll dried blood spot.

A fixed amount of

labelled phenylalanine (10 n mole) was used for each analysis.

The

peak height ratios (Phe m/e 222 vs Phe-D5 m/e 227) were determined
from the mass spectra.

The composition of the labelled Phe used was

4% DQ-, 2.7% Di-, 4% D2-, 13.5% D3-, 29% D4-, 37% D5-, 7% D^-, and
2.8% Dy.

o
M
H

s

<
W
PM

MOLAR

RATIO

(Gly / Gly-D2 or Val / Val-D5)
Fig. 8.

Calibration curve for the quantitative determination of
glycine and valine.

Whole blood was supplemented with

glycine and valine to produce concentration of 0 to 5 n
mole per 5 yl dried blood spot.

A fixed amount of la-

belled glycine and valine (10 n mole) was used for each
analysis.

The peak height ratios (Gly m/e 132 vs

Gly-D2 m/e 134; and Val m/e 174 vs Val-D5 m/e 180) were
determined from the mass spectra.

Table 3.

Recoveries of amino acids added to blood spots.

Standard amino

acids (D^, 5 n mole) were added to whole blood prior spotting.
The blood spots were punched, amino acids were extracted with
80% ethanol solution.

Immediately prior to the removal of the

filter paper blood disc a known amount of labelled amino acid
standards (D^, 10 n mole) were added.

Peak height ratio were

computed and the results were compared with that of control
samples with added D^ after extraction.

Blood Spot
+

Blood Spot Extract
+

Amino Acid

Amino Acid

(kA/AA*)^

(AA/AA*)

Recovery,

Amino
Acids

C.V.,

Gly

1.23

1.26

98

3.1

Val

0.69

0.71

97

2.8

Asp

0.55

0.54

101

2.2

Glu

0.47

0.51

92

2.3

Phe

1.50

1.55

97

2.0

Tyr

0.56

0.60

93

2.1

^Average of five analyses
Coefficient of variation
^Unlabelled to labelled amino acid ratio
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level of the PKU sample to be 20.2 mg %.
We further checked our analytical technique by analyzing four PKU
blood spot samples five times each and comparing our data with the results
obtained from classical ion-exchange chromatography (Table 4).

The good

reproducibility and the excellent agreement of our blood spot analyses
with the corresponding ion-exchange plasma amino acid analyses suggests
that the new technique accurately determines the free Phe content of the
plasma.
In other experiments, we compared the M.S. blood spot phenylalanine
analyses with results obtained from the semi-quantitative bacterial assay(54)
Guthrie test

(Table 5).

This was done using four control Guthrie

blood spot specimens in duplicate.

Each of the blood spot disc was ex-

tracted with 80% ethanol containing 12.5 nanomole phenylalanine-D^.

The

mass spectra (5 scans per analysis) were then recorded and the concentration of phenylalanine in the blood were calculated.

We also established,

by doing the blood spot analysis on several one-year old Guthrie blood
spot specimens, that the amino acid content of those samples was quite
stable upon storage.
We have also shown that other inherited diseases such as maple syrup
urine disease (MSU), hyperglycinemia and tyrosinemia can be diagnosed from
the blood spot mass spectral profile (Figs. 10, 11 and 12) as in each case
abnormal quantities of one or more amino acids are shown to be present.
Under routine operating conditions it has been established that the
specificity of the new technique permits the determination of all the
common blood amino acids down to a level of 25 n moles, whilst still
maintaining a signal to noise ratio better than 10:1.

Other low molecular

weight blood constituents such as cholesterol, fatty acids and organic
acids, show ions in the mass spectra but do not interfere with the

Table 4.

Phenylalanine analyses of Phenylketonurie blood and plasma
by mass spectrometry and ion exchange chromatography

Mass Spectrometry (blood spot)
Patient

Concentration
(mg %)

G.L.

Ion Exchange (plasma)

Mean + S.E.M.

Mean^

(mg %)

(mg %)

18.53 + 0.30

18.81

20.60 + 0.25

20.30

15.01 + 0.29

15.80

13.09 + 0.24

13.04

18.24
18.10
18.68
18.53
18.83

F.T.

20.89
20.60
20.45
20.74
20.30

W.M.

14.86
15.16
15.01
14.57
15.30

S.S.

12.80
13.39
13.09
12.95
13.24

S.E.M. = Standard Error of Mean
Average of two analyses

Table 5.

Phenylalanine analyses of Guthrie blood spot by CI mass
spectrometry and Guthrie bacterial inhibition assay

Sample

CI-MS Method

Guthrie Assay

(mg %)

(mg %)

A

6.70

6.73

7

B

5.54

5.55

6

C

7.06

7.10

6

D

5.97

5.97
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quantitative amino acid analyses.

For example, small amounts of 03^2-0

^20:0 fatty acids are extracted

aqueous alcohol from the blood spot

and are esterified by acetic anhydride-methanol to yield fatty acid methyl
esters (Table 6).
Since we have noticed that the relative intensity of all the blood
amino acid in normal specimens is fairly constant, it is often possible to
detect an unexpectedly high abundance of an amino acid or the presence of
an unusual amino acid even without the addition of a labelled standard
(Figs. 13 and 14).
We then decided to apply this new analytical technique to the
analysis of other physiological fluids, such as plasma, serum, urine,
amniotic fluid, and saliva.

For the analysis of plasma and serum, a

deproteinization step is required, but urine, saliva or amniotic fluid can
be used directly for the analysis.
Again the CI-MS results from 6 PKU plasma samples were compared with
those obtained by ion-exchange chromatography (Table 7).

The good re-

producibility and the excellent agreement of the data with the corresponding ion-exchange method shows that the new technique accurately determines
plasma phenylalanine levels.
Similar experiments were also carried out with tyrosine, glycine and
valine as abnormal plasma levels of these amino acids are also indicators
of other hereditary disorders such as tyrosinosis, hyperglycinemia and
maple syrup urine disease.

Table 8 shows the amino acid concentration

determined By CI-MS for a normal, tyrosin^^ic, hyperglycinemic and
maple syrup urine affected plasmas.

The results shown are the average

obtained from two separate analyses and are expressed in mg/100 ml plasma.

Table 6.

Protonated molecular ions (MH*^) for biological important
fatty acids derivatized as methyl esters by acetic
anhydride-methanol reagent

Fatty Acid

(MH"'')

^2:0

215

^14:0

243

^16:0

271

^6:1

209

48:0

299

^18:1

297

^18:2

295

^18:3

293

^20:0

327

S0:4

319
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Table 7.

Phenylalanine analyses of phenylketonuria plasma by
mass spectrometry and ion exchange chromatography

Mass Spectrometry
Patient No

Ion Exchange Chromatography^
(Mg %)

(Mg %)

1161

12. 91^

0. 24^

12. 54^

1162

18.,86

0. 31

18. 15

1163

15..91

0,,27

15. 35

1164

16..26

0.,28

16. 14

1165

15,.84

0..27

15.,82

1166

15,.56

0..29

15.,51

^Analysis was conducted by L. B. James, John Curtin School of Medical
School, A.C.T. 2601, Australia
Average of three analyses
^Standard Error of Mean
^Average of two analyses

Table 8.

Amino acid plasma levels for tyrosinesis, hyperglycinemia,
and maple syrup urine disease (mg %)

Disorder

Amino Acid

Patient

Normal Control

Tyr

21.55

(1.25)

Phe

1.22

(1.02)

(Pre-exchange)

Gly

14.15

(2.11)

(Post-exchange)

Gly

5.62

Val

20.64

Tyrosinosis

Hyperglycinemia

Maple syrup urine

(2.37)

In other experiments we analyzed blood phenylalanine/tyrosine ratios
which can be used to detect PKU heterozygosity.

In these experiments the

patient was given an oral load (up to 100 mg/kg body weight) of phenylalanine and the Phe and Tyr plasma level was monitored and the Phe/Tyr
ratio calculated.
Table 9.

The results from these experiments are summarized in

The results show that the phenylalanine plasma profiles of an

heterozygote can be distinguished from that of a normal individual
(Fig. 15).
The method was also applied to the analysis of human saliva, amniotic
fluid and urine specimens.

In each case fifty microliter samples of

these biological fluids are required.

For example, saliva was collected

from five male subjects in good general health between the ages of 25-30.
Before sample collection, the subjects were required to rinse out the oral
cavity with distilled water several times.

Samples of saliva were obtained

by expectoration into glass beakers, and the samples were pooled for
analysis.

The mass spectral analyses of amino acids from five runs of

pooled saliva samples are summarized in Table 10, and indicate the reproducibility attainable for these types of samples.

No published data

for saliva amino acids are available, so it was not possible to compare our
results with published values.
A comparison of phenyalanine saliva levels in two PKU patients with a
normal was also made.

The results show that the Phe content of the patient

was four times that of a normal (Table 11).

This is not as high as the

levels found in blood (30 times normal) and thus saliva does not seem
particularly suitable for PKU diagnostic purposes.
Similar experiments were also carried out using samples of amniotic
fluids.

Fifty micro-liter of pooled amniotic fluid were used for this

Table 9.

Plasma levels of phenylalanine and tyrosine, and phenylalanine
to tyrosine ration in PKU heterozygote

Time-course

Phe

Tyr

Phe/Tyr Ratio

(Mg %)

(Mg %)

1.03

1.05

0.98

1 h

10.28

2.33

4.41

2 h

6.39

1.45

4.40

4 h

4.27

1.25

3.42

Before Phe load

After Phe load

Heterozygote
o
M
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H
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Normal Control

0
HOUR AFTER PHENYLALANINE LOAD
Fig. 15.

Phenylalanine loading test.
time after the load.

Phe/Tyr ratio vs

Table 10.

Physiological amino acids levels of saliva and amniotic
fluid.

Normal adult and pregnant subjects were used

for the complete procedure.

Amniotic Fluid

Saliva
Amino Acids
Mg %

c.v., %

C.V., %

Mg ^!

2.5''

Gly

0.47^

2.3^

1.11^ (0.9-1.3)^

Val

1.33

1.9

0.72

(0.5-2.3)

2.1

Asp

0.37

2.1

0.50

( —

)

2.0

Glu

0.44

1.9

1.21

(1.1-3.3)

1.8

Phe

0.52

1.7

0.68

(0.3-1.2)

1.9

Tyr

0.52

1.9

0.47

(0.3-1.3)

1.8

^Average of five analyses
'c.V. = Coefficient of Variation
'Reference N o . 72

Table 11.

Phenylalanine analysis of PKU saliva
and plasma by mass spectrometry

Patient

PKU Saliva

PKU Plasma

(Mg %)

(Mg %)

S.L.

2.41^

27.82^

M.V.

2.36

29.28

0.52

1.10

Normal control

Average of two analyses

p u r p o s e and the r e s u l t s for some a m i n o acids are summarized and compared
w i t h the p u b l i s h e d data (Table

10).

F o r the a n a l y s i s of u r i n e a 24-hour u r i n e was obtained from three
normal male subjects.
CI-MS.

T h e s e w e r e p o o l e d and derivatized and analyzed by

T h e r e l a t i v e p e a k h e i g h t v a l u e s of the urinary amino acids in

this s a m p l e a r e s h o w n in T a b l e 1 2 .

I t w a s n o t e d that a m o l e c u l a r ion peak

for c r e a t i n i n e a t m / e 156 and for h i p p u r i c acid at m / e 194 w e r e also present in the s p e c t r u m .

T h i s suggests that suitable M S techniques for the

q u a n t i t a t i v e a n a l y s i s of these m e t a b o l i t e s w i l l be possible provided
l a b e l l e d i n t e r n a l s t a n d a r d can be p r e p a r e d .
A t the time of w r i t i n g , w e h a v e confirmed the suitability of the
a n a l y s i s for m o s t p r o t e i n amino acids w i t h the exception of s e r i n e ,
t h r e o n i n e , h i s t i d i n e , c y s t e i n e , cystine and a r g i n i n e .

Labelled standards

of some of these amino acids are b e i n g p r e p a r e d , and some are being obtained from c o m m e r c i a l

sources.

T h e p o s s i b i l i t y of u s i n g c o m m e r c i a l l y available stable isotopically
l a b e l l e d a l g a l p r o t e i n h y d r o l y s a t e as internal standard is also being
examined.
I n v i e w of our success w i t h the blood amino acid a n a l y s i s , w e looked
at the p o s s i b i l i t y of a n a l y z i n g for other blood metabolites by the same
approach.
T h e l i t e r a t u r e suggests that a m i x t u r e of chloroform and m e t h a n o l in
the r a t i o of 2:1 (v/v) w i l l e x t r a c t lipid m o r e exhaustively from biologic a l m a t e r i a l s than m o s t o t h e r simple solvent systems and w e h a v e confirmed
that s o n i c a t i o n w i t h this solvent m i x t u r e extracts fatty a c i d s ,
c h o l e s t e r o l and t r i g l y c e r i d e s from the b l o o d s p o t .

Table 12.

Relative peak height values of amino acids found in human
urine by c.i. mass spectrometry.

Normal adult subjects,

pooled of three, were used for the complete procedure.
Values represent an equivalent to 15 ]il urine.

+

(QH)

Compound

Temperature of Solid Probe
70° C.

120° C

180° C

Peak Height (mm)
132

Gly

43

33

3

146

Ala

93

7

3

174

Val

10

6

4

188

Leu + H e

9

3

1

a

b

^(QM)

204

Asp

11

24

3

206

Met

34

6

1

230

Hpr

35

46

1

245

Lys

5

7

11

= 156.

^(QM)"*" = 194.

Creatinine (peak heights 120-280)
Hippuric acid (peak heights 9-110)

Preliminary experiments with individual free fatty acids showed they
could be readily detected by CI-MS at solid probe temperatures between
100-200°C.

The CI mass spectra of the saturated and the unsaturated free

fatty acids were dominated by large protonated molecular ion peaks (MH+)
and unique m/e values were obtained for all biologically important fatty
acids in the range Cx2:0 to C20:0 (Table 13).
For quantitative work, we decided to use deuterium labelled fatty
acids as internal standard.

These were difficult to obtain from commer-

cial sources and thus the preparation of some labelled fatty acid standards
was necessary.

The literature contains a number of approaches on the

preparation of deuterium labelled fatty

a c i d s , 7 4 ) ^

Xhe published

methods use platinum and basic conditions at elevated temperatures.

Our

results using this method were disappointing as it was difficult to control the level of deuterium incorporation.

Another published approach to

labelled fatty acids uses D2SO4 as a c a t a l y s .

By a slight modifica-

tion of this technique in which we used (CD3CO)20 to solubilize the fatty
acids in the reaction mixture we are able to produce a-labelled D2 fatty
acids.

This new procedure was experimentally quite simple and up to 93%

D2 incorporation could be obtained using incubation at 160°C overnight.
The mass spectra of the labelled compounds were recorded and the
isotopic composition of the labelled fatty acids was determined by M.S.
Table 14 shows the percent of D incorporation into the labelled fatty
acids prepared by this route.

The individual deuterated fatty acid

standards were then combined into one standard chloroform solution.
Our attempts to label unsaturated fatty acids such as C^^.i or Ci8:l
by this route were not successful and therefore our initial quantitative
work was confined to the saturated fatty acids.

Table 13.

Chemical ionization mass spectral data
for free fatty acids

Fatty Acid

(MH)"''

Laurie

^12*0

^^^

Myristic

^14:0

^^^

Pantadecanoic

^15-0

Plamitic

^16:0

Palmitoleic

^^^
255

Stearic

^18:0

^^^

Oleic

^18:1

^^^

Linoleic

^18*2

^^^

Linolenic

^18*3

^^^

Arachidic

^20*0

^^^

Arachidonic

^20-4

^^^

Phytanic

^20:0

^^^

Table 14.

Chemical ionization mass spectrometry of prepared
a-deutero fatty acids

Fatty Acid

D^ %
(peak height)

Laurie acid

^^
Q)

0.10

91

Palmitic acid (C^^.Q^

0-13

88

Stearic acid (C^g.Q^

0-16

86

Phytanic acid (^29-0^

0.10

91

Myristic acid

In our first experiments, different quantities of a reference solution
of fatty acids containing lauric acid (Cx2:0)) myristic acid (03^4.0),
palmitic acid (CI^^.Q)

stearic acid (C^^g.Q) and a fixed amount of the

internal standards (lauric acid-D2, myristic acid-D2, palmitic acid-D2 and
stearic acid-D2) were mixed and concentrated and introduced into the M.S.
Calibration curves for these fatty acids were then determined by comparing
the protonated molecular ion (MH"^) peak height of a concentration range of
unlabelled fatty acids with that of the appropriate isotopically labelled
fatty acid.

Graphical analysis of the data confirmed the linearity of the

assay (Fig. 16).

The slopes of the calibration line were then used to

calculate the calibration factor which corrects the results for the
chemical and isotopic purity of the internal standards.

The technique was

then applied to the analysis of a synthetic fatty acid mixture and the results were compared with the data obtained from a gas-liquid chromatographic
analysis of the same mixture (Table 15).

The good reproducibility and the

excellent agreement of our analysis with the corresponding gas-liquid
chromatographic analysis suggests that the new technique accurately determines the free fatty acid content of the mixture.
We further checked our analytical technique by analyzing an artificially prepared blood sample supplemented with different amounts of stearic
acid.

For the analysis, the blood spots were extracted with CHCl3-MeOH

containing a fixed amount of stearic acid-D2 as internal standard.

The

mass spectra were then recorded and the concentration of the stearic acid
in the blood was calculated.

These spectra were compiled by taking five

mass spectral scans and manually measuring the peak heights of MH+ ions of
Cl8:0

285) and C^siO'^Z

^^^^

^^^ ^^^^

ratios (m/e 285 vs. m/e 287) were then calculated and the average value
was used for the final calculation of Ci8:0 concentration in the blood.

Free Fatty Acid
Fig. 16.

(^g)

Calibration obtained from a fatty acid
mixture containing lauric acid, lauric
acid-D2, myristic acid, myristic acid-D^
palmitic acid-D2, and stearic acid,
stearic acid-D2.

Table 15.

Analysis of fatty acid mixture by chemical ionization
mass spectrometry and gas chromatography

Fatty Acid

Mass Spectrometry

Gas Chromatography

w/w

S.D.^

w/w

S.D.^

^12:0

18.66

0.56

18.41

0.64

^4:0

17.91

0.52

18.11

0.62

^6:0

35.45

0.96

35.80

1.10

^18:0

27.99

0.78

27.68

1.02

Average of five determinations
^Standard Deviation

T h e linearity of the assay (Fig. 17) indicated that the blood spot
technique was suitable for the analysis of various levels of Cj^g.Q and
similar results w e r e also obtained for

CJ^^.Q

and C]^5.o acids.

The technique was then employed to determine the free fatty acid
components of blood spotted on filter paper (Table 16).

This was done

with one blood spot disc containing 5.5 P I blood and the blood fatty acids
w e r e extracted with CHCl3-MeOH containing the appropriate labelled fatty
acid s t a n d a r d s .

The extract was then concentrated and analyzed by C I - M S .

A g a i n , peak h e i g h t ratio of 5 scans w e r e obtained and average value was
used for final calculation of free fatty acid concentration.
T h e next step was to apply this new microanalytical method to the
analysis of small samples of blood from a genetic screening program for
disorders of fatty acid metabolism such as Refsum's disease.
In the patient with Refsum's disease there is an accumulation of
exogenously derived phytanic a c i d , a C20:0 branched chain fatty acid
n a m e l y 3,7,11,15-tetramethylhexadecanoic a c i d , in the tissue and serum of
the p a t i e n t .

In our first experiment w e prepared deuterated phytanic

acid-D2 by the same procedure as described previously.

By using a fixed

amount of phytanic acid-D as internal standards, a calibration curve for
phytanic acid was established for the expected concentration range.
G r a p h i c a l analysis of the data again confirmed the linearity of the assay
(Fig. 1 8 ) .

In later experiments, w e also confirmed the linearity for an

a r t i f i c i a l l y prepared blood sample supplemented with different amounts of
p h y t a n i c acid and this calibration curve was found to be identical with
the standard calibration c u r v e .

These results suggested that normal blood

contains negligible amounts of C20:0 ^ c i d s .

This is not the case for a

blood spot sample from a patient suffering from Refsum's disease.

This

y i e l d e d a significant (MH+) at m/e 313 for phytanic acid (Fig. 19) and the

2.0

3.0

Stearic Acid C^g.o (pg)
Fig. 17.

Calibration curve for the quantitative determination of stearic acid in blood.
supplemented with stearic acid

Blood was

(0^3.q, MW=284)

to produce concentration of 0.5, 1.0, 2.0 and
3.0 yg per 20 yl dried blood spot.
amount (2 yg) of stearic acid-D
was used for each analysis.

A fixed

(C13.0, MW=286)

Table 1 6 .

Analysis of blood spots by chemical
ionization mass spectrometry

Mg

^12:0
^14:0
^16:0
^8:0
a

Patient B

Patient A

Fatty A c i d ^

S.D."

Mg

S.D.^

0.24

0.01

0.39

0.01

2.00

0.06

2.15

0.05

10.44

0.29

8.69

0.25

3.48

0.09

3.04

0.08

Plasma free fatty acids have been determined by gas chromatography.
The literature (48) suggests that the levels are from 1.0-2.8 mg %
( C ^ ^ . q ) , 0.4-11.3 m g % ( C ^ ^ . q ) and 0.2-3.9 mg % ( C ^ ^ g . Q ) .

^ A v e r a g e of five determinations
^Standard Deviation
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concentration of this acid in the blood of the patient was shown to be
16.40 + 0.46 mg
CI-MS permits the determination of all common free fatty acids in
blood down to a level of 25 ng at a signal/noise ratio better than 10:1.
Other low molecular weight blood constituents such as cholesterol, cholesterol esters, triglycerides and other organic acids which may be present
in the mass spectra do not interfere with the analysis.

Underivatized

amino acids, peptides and other blood constituents are either insoluble
in the extraction solvent or not sufficiently volatile for direct mass
spectrometry.
We next looked at the possibility of determining blood cholesterol by
this method.

When cholesterol was exposed to t-C4H9+ ions in the mass

spectrometer at a probe temperature of 140-160°C most of the cholesterol
was dehydrated and the base peak of the mass spectrum was at m/e 369
(Fig. 20).

The other peaks in the spectrum were at m/e 387 (4.5%),

m/e 386 (4.5%), and m/e 486 (9.1%) which correspond to (MH)*^, (M)+, and
(M-H)^, respectively.
For quantitative work, deuterated cholesterol was prepared according
to a published

procedure(76)

and the sample prepared by us contained

(4%), D2 (12%), D3 (24%), D4 (32%) and D5 (28%) as shown by MS analysis
(Fig.

20).
For calibration purposes, a fixed amount of labelled cholesterol

(1.0 yg) was added to varying amounts of a reference cholesterol solution
and the peak height ratios at m/e 369 and m/e 373 were monitored.
Graphical analysis of the data confirmed the linearity of the assay
(Fig. 21).
It was also possible to establish the calibration curve, but at a
reduced sensitivity, by comparing the sum of the peak heights of the (M)"

(a)

(c)

(b)
373

369

(MH'^-H20)
373

(MH'^-H20)
369

390
385

MH
387
X jl
390

ON
U)

MH"^
391

+

—

380

Fig, 20.

370

360 m/e

390

380

370

360 m/e

390

«

—

380

370

360 m/e

The c.i. (isobutane) mass spectral analysis of (a) cholesterol, (b) cholesterol-D^^ and (c) cholesterol + cholesterol-D^^ (1:1 w/w) .
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1.5

2.0

( pg )

Calibration curves for the quantitative determination
of cholesterol,

A fixed amount of deuterated choles-

terol (1 Ug) was used as internal standard for each
analysis.

and (M-H)"^ at m/e 386 and m/e 385 to that of the corresponding labelled
standard at m/e 390 and m/e 389.

The cholesterol standard curve (dehy-

drated peaks) was then used to calculate the calibration factor which
corrects the results for the chemical and isotopic purity of the internal
standards.
The linearity of the assay was further confirmed by repeating the
calibrations on artificially prepared blood spiked with cholesterol
(Fig. 22).

The experiments were then carried out using whole blood to

which additional reference cholesterol had been added so that the 5 yl
blood spot samples contain a concentration range of 0-10 yg of cholesterol.
For the analysis, the blood spot was extracted with CHCI3 - MeOH (2:l,v/v)
reagent containing a fixed amount (5.0 yg) of labelled cholesterol.
mass spectra were then recorded at probe temperature 150 + 10°C
concentration of the cholesterol in the blood was calculated.

The

and the

As pre-

viously this was done by taking five mass spectral scans and manually
measuring the peak heights at m/e 369 and m/e 373 for each scan and
averaging the result.

The effect of the presence of cholesterol esters on

the assay was then checked by adding cholesterol esters, e.g., cholesteryl
palmitate and cholesteryl stearate (10.0 yg each) to the blood.

The re-

sults of these experiments showed that our procedure only measure "free"
cholesterol.
The method was then used to analyze free cholesterol in normal blood.
For this a 5 yl blood spot disc (4 mm diameter) was punched out and the
cholesterol and other lipids were extracted with CHCI3 - MeOH containing
the appropriate labelled cholesterol standard (5.0 yg).

Table 17 shows

the CI-MS and thin layer chromatography analytical results on several
blood cholesterol samples.

The free cholesterol data indicate good

agreement between the CI-MS and the TLC methods(77).
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Calibration curve for the quantitative determination of
cholesterol in blood.

Blood was supplemented with choles-

terol to produce concentration of 0 to 10.0 ]Jg per 5 yl
dried blood spot.

A fixed amount (5 Ug) of cholesterol-04-

was used for each analysis.

The dehydrated ion peaks of

cholesterol at m/e 369 and of cholesterol-D4 at m/e 373
were used for the determination of peak height ratio.

Table 17.

Comparison of blood analysis for free cholesterol,
as obtained by mass spectrometry and thin-layer
chromatography

Blood Sample
^^ ^^^

Free Cholesterol (mg %)
Mass Spectrometry^

TLCb

1

58.5

58.2

58.9

2

67.0

66.6

65.1

3

55.1

55.7

56.2

4

75.5

75.0

74.3

5

60.8

61.6

62.0

^Deuterium labelled cholesterol (ca. 5 Ug) was used as internal standard
Solid probe temperature was at 150 + 10° C. Average of five spectral
scans was used for each analysis.
^Average of two analyses

To evaluate our new method with present day clinical cholesterol
assays, it was necessary to determine total blood cholesterol as all the
present methods only determine the latter.

To do this we carried out an

alkaline hydrolysis to release bound cholesterol from its lipoprotein
complexes and its esters.

This was done by heating a sodium methoxide

(Na/MeOH) solution of the serum containing the internal standard at 100°C
for 15 minutes.

Table 18 shows the mass spectral and enzymatic results^^^)

for total cholesterol in serum.

The results indicate that the serum

total cholesterol content as determined by the two methods is within 5%.
Following these experiments, we also evaluated the new blood spot
analysis for both free cholesterol and total cholesterol content.

For

this analysis, the blood spot (5 Ul) was sonicated with CHCl3-MeOH reagent
containing a fixed amount (5.0 Pg) of labelled cholesterol.

As previously

an aliquot of the extract was introduced to the MS for the free cholesterol
determination whilst the remaining portion was hydrolyzed with Na/MeOH
solution (50 yl) and then evaporated and redissolved in hexane.

The re-

sults of five such separate analyses are summarized in Table 19.
We further checked the possibility of analyzing blood cholesterol
esters by this method.

To do this we examined the mass spectra of

cholesteryl stearate and cholestryl palmitate and found that, unlike the
free cholesterol, the cholesterol esters of biological interest volatized
at much higher probe temperature, e.g., 250-300°C.

At these probe tem-

peratures, the mass spectra of the cholesterol esters primarily showed
the "dehydrated ion peak" of cholesterol (m/e 369) and the protonated
(MH)+ peak of the corresponding fatty acid, e.g., Cie-.o
C^g.Q (m/e 285).

^^^^ ^^^

These results are in agreement with the recently

published work of Murata et al.(79)^

Table 18.

Comparison of serum analysis for total cholesterol,
as obtained by mass spectrometry and the enzymatic
method

Total Cholesterol (mg %)
Serum
Mass Spectrometry

Enzyme Method^

1

219.2

222.3

221.8

2

238.5

236.1

242.1

3

240.5

238.6

234.7

4

100.1

101.7

99.9

5

224.1

226.5

227.8

6

243.6

246.3

252.5

^Calbiochem Enzymatic Cholesterol S .V.R. Doc No. L06011, August 1, 1975

Table 19.

Blood analysis for free and total cholesterol
by mass spectrometry.

Free Cholesterol (mg %)

Mean:
S.D.

Blood spot (S.L., 5 Ul)

Total Cholesterol (mg %)

75.62^

196.75^

77.20

195.50

76.11

194.06

76.96

195.71

77.08

196.12

76.59

196.63

0.64

1.08

^Average of five scans for each analysis.
150°C

Probe t° =

For calibration purposes, a fixed amount (5 Ug) of labelled cholesteryl
palmitate or cholesteryl stearate which was prepared by a published
method(80)

^as added to varying amounts of a reference unlabelled choles-

terol ester solution and the peak height ratio at m/e 369 and m/e 373 were
monitored.

The calibration experiments were also carried out by using

whole blood (Fig.23) to which additional reference cholesteryl palmitate
or stearate ester had been added so that the 5 yl blood spot samples contain a concentration range of 0-9 Ug of cholesterol esters.

For the

analysis, the blood spot was extracted with CHCI3 - MeOH reagent containing a fixed amount of labelled cholesteryl palmitate.

The mass spectra

were then recorded at probe temperature of 270 + 10°C and
tion of the cholesterol esters in the blood was calculated.

the concentraThe effect of

the presence of free cholesterol on the assay was checked by adding
cholesterol (10 ]ig) to the blood.

The results of these experiments showed

that our procedure only measure esterified cholesterol.
The method was then used to determine esterified cholesterol in
normal blood.

For this a 5 yl blood spot disc was used and the total

cholesterol and other lipids were extracted with CHCl^ - MeOH containing
the labelled cholesteryl palmitate (5.0 yg) . Table 20 summarizes the
results obtained from the mass spectrometric analysis of cholesterol after
alkaline hydrolysis of blood and by direct mass spectrometric blood
analysis.
The direct estimation of blood esterified cholesterol also allows
us to measure the relative abundance of the physiologically important
cholesterol esters commonly found in blood; namely, cholesterol esters of
^16:0-^20:4 f^tty acids.
When individual cholesterol esters, e.g., cholesteryl palmitate or
cholesteryl stearate, are analyzed by MS at probe temperature of 270°C
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PALMITATE ( lig )

Calibration curve for the quantitative determination of cholesteryl palmitate ester in blood.

Blood was supplemented

with cholesteryl palmitate to produce concentration of 0 to
9.0

g per 5

1 dried blood spot.

A fixed amount (ca. 5

of deuterium labelled cholesteryl palmitate was used for
each analysis.

The dehydrated ion peaks of cholesterol

esters at m./e 369 and of deuterated cholesteryl palmitate
at m/e 373 were used for the determination of the peak
height ratio.

g)

Table 20.

C o m p a r i s o n of b l o o d a n a l y s i s for e s t e r i f i e d

cholesterol,

as o b t a i n e d b y m a s s s p e c t r o m e t r y w i t h or w i t h o u t alkaline hydrolysis

Blood Sample
(5 y i )

E s t e r i f i e d C h o l e s t e r o l (mg % )
Hydrolysis

Method^

Direct Mass

Spectrometry^

1

90.98

92.05

91.75

92.52

2

131.61

132.72

130.45

133.42

3

80.18

79.59

79.32

81.06

4

120.86

120.17

119.04

120.21

5

140.09

141.37

142.18

143.52

^ D e u t e r i u m l a b e l l e d c h o l e s t e r o l ( c a . 5 y g ) w a s used as i n t e r n a l standard
for the a n a l y s i s of free and total c h o l e s t e r o l a f t e r a l k a l i n e h y d r o l y s i s .
T h e s o l i d p r o b e t e m p e r a t u r e w a s h e l d a t 150 + 10°C. T h e figures quoted
a r e a n a v e r a g e of f i v e s p e c t r a l s c a n s . E s t e r i f i e d c h o l e s t e r o l v a l u e s
w e r e c a l c u l a t e d f r o m the t o t a l c h o l e s t e r o l v a l u e m i n u s the free cholesterol .
^ D e u t e r i u m l a b e l l e d c h o l e s t e r y l p a l m i t a t e ( c a . 5 y g ) w a s used as i n t e r n a l
s t a n d a r d for the a n a l y s i s of e s t e r i f i e d c h o l e s t e r o l ( e s t e r s ) . T h e solid
p r o b e t e m p e r a t u r e w a s h e l d at 270 + 10°C. T h e figures quoted are an
a v e r a g e of five s p e c t r a l s c a n s .

the p e a k h e i g h t ratio o f the dehydrated cholesterol ion (m/e 369) and the
c o r r e s p o n d i n g fatty acid protonated ions (m/e 257 for C^^^.Q and m/e 285 for
^18:0^ can be d e t e r m i n e d .

W h e n a m i x t u r e of the above esters is analyzed

u n d e r the same c o n d i t i o n s , the corresponding fatty acid peaks can also be
recorded and the peak h e i g h t ratios can be calculated (Table 21).

The

data show that the m e t h o d can also be used to determine the relative
a b u n d a n c e of the fatty acid components derived from them (Table 22).

Our

m e t h o d thus allows us to estimate both the level and composition of
c h o l e s t e r o l esters in b l o o d .
Since estriol levels reflect foetal w e l l - b e i n g , particularly during
the late stages of p r e g n a n c y , there is a clinical need for a rapid analysis.
W e h a v e also examined the applicability of the mass spectrometric

technique

for this p u r p o s e .
A sufficient amount of estriol for our analysis could be extracted
with diethyl ether from only 100 yl o f , acid h y d r o l y z e d , pregnancy urine
and the mass spectrum of estriol showed peaks at m/e 289 (50% intensity)
and m / e 271 (50% intensity) which corresponds to the protonated molecular
ion (MH"^) and the dehydrated ion (MH-H^D)"^, respectively (Table

23).

By u s i n g a fixed amount (4 y g ) of estriol-D2 (m/e 291) which was
prepared by a published method(81), a calibration curve for estriol
(m/e 289) was determined for a 0-9 Pg concentration range.

Graphic

analysis of the data confirmed the linearity of the assay (Fig. 2 4 ) .

The

technique was then employed with hydrolyzed urine specimens by spiking
w i t h a solution of the appropriate estriol-D2 as internal standard.

The

m a s s spectral results w e r e compared with those obtained by a fluorescence
a u t o a n a l y z e r method (Table 24).

The data indicate that mass spectral

results are consistently lower than those obtained by the fluorimetric
method<^2).

This is due to the fact that the classical method measures

Table 21.

M a s s spectral data on cholesterol esters.
Probe tO = 270°C.

(Cholesterol/Fatty A c i d ) Ratio
C h o i , (m/e 369)

C h o i , (m/e 369)

^ 1 6 : 0 (m/e 257) Cl8:0 (m/e 285)

Fatty Acid Ratio^
Cl6:0 (m/e 257)
^16:0 (m/e 285)

0.93

0.94

1.18

0.94

0.97

1.19

1.06

0.90

1.22

1.00

0.88

1.09

1.00

0.87

0.92

Mean:

0.99

0.91

1.12

S.D.

0.05

0.04

0.11

^Cholesteryl palmitate:

cholesteryl stearate (1:1 w/v)

Table 22.

Mass spectral data on fatty acids derived from cholesterol
esters in blood.

Solid probe temperature 270 + 10°C.

Blood Sample (5 yi)
Fatty Acid

(MH)"^
m/ e

(A)

(B)

(G)

(D)

(E)

(F)

^16:0

257

100

100

100

100

100

100

^16:1

255

29

27

28

26

24

30

^18:0

285

45

62

58

66

44

48

^18:1

283

55

69

70

59

44

50

^18:2

281

23

23

18

33

16

24

^18:3

279

16

23

15

17

12

19

^20:0

313

55

39

33

66

20

15

^20:1

311

13

15

16

20

9

10

^20:4

305

-

-

-

-

-

-

Table 2 3 .

Isobutane CI-MS analysis of estrogens

(MH)+
,
m/e

(MH - H20)"^

MW

Estrone

270

271

253

Estradiol

272

273

255

50 : 50

Estriol

288

289

271

50 : 50

Estrogen

m/e

Ion Peak Intensity

100 :

1

0

2

4

6

8

ESTRIOL CONCENTRATION, ^ g
Fig. 24.

Calibration curve obtained from a mixture of estriol
and estriol-D2.

A fixed amount (4 yg) of estriol-D2

was used for each analysis.

Table 24.

Analysis of estriol (mg/liter) in pregnancy urine
by CI-MS and fluorimetry

Urine

Mass Spectrometry^

Fluorimetry

1

9.12 + 0.27

10.34

2

10.89 + 0.26

11.42

3

8.67 + 0.26

9.08

4

10.75 + 0.29

11.21

5

12.65 + 0.33

13.23

6

9.27 + 0.26

10.59

7

13.53 + 0.39

14.78

8

8.79 + 0.25

9.68

^ e a n + standard error of mean (from three determinations)

the total estrogens, e.g., estrone, estradiol and estriol, etc.
A recovery study was therefore carried out by adding increasing
amounts of estriol to the hydrolyzed urine sample and measuring the increases in peak height ratio due to these additions as compared to the
response of samples with zero addition.

Recovery values for estriol ranged

from 94-103%.
The quantitative analysis of protein hydrolysates is of considerable
importance to research in many of the biosciences.

We therefore have

investigated the applicability of mass spectrometry in this field by
analyzing a number of pure peptide hydrolysates.
For the analysis, each peptide hydrolysate was divided into two portions, one of which was analyzed by ion-exchange chromatography and the
other by direct mass spectrometry.

Table 25 shows the results expressed

as moles of amino acid present in each peptide as obtained by the two
methods.

The good agreement between the two analyses suggests that the

new technique, which only takes 15 minutes as compared to 3-4 hours for
ion-exchange chromatography, may have some value in this field.
It seemed pretty obvious that the new technique will also be quite
useful for some non-clinical problems.

It so happened that this department

has been interested in the use of stable isotopically labelled substrates
for the diagnosis and study of genetic defects.

In these experiments, a

stable isotopically labelled substrate is administered orally to the
patient and the appearance and level of deuterated substrate and its
metabolites in the body fluids are followed in a time course experiment.
We have used the new amino acid analysis to determine the ratio of labelled
to unlabelled serum and urinary amino acids.

For these analyses, serum or

urine was treated as described previously and the molecular ions of the
corresponding N-acetyl amino acid methyl esters were monitored and recorded.

Table 25.

Comparison of ion-exchange results and values determined
in this study for amino acids derived from peptide hydrolysates

Peptide
Hydrolysate

A.

B.

C.

D.

Amino Acid Residue (mole)
Mass Spectrometry^

Ion-Exchange Chromatography

Asp

1.1

1.1

Phe

1.0

1.0

Gly

1.1

1.0

Met

1.0

1.0

Phe

1.1

1.1

Asp

1.0

1.0

Gly

0.98

0.95

Met

1.04

0.88

Phe

0.95

0.98

Met

1.0

1.0

Asp

1.1

1.3

Val

1.3

1.2

Glu

1.0

1.3

Leu

1.2

1.2

Phe

1.0

1.2

a
Average of two analyses. 50 yl hydrolysate equivalent to 2-8 yg of
peptide was spiked with 12.5 n mole of the correspondingly labelled
amino acid standards.

In this way, the deuterium content of the serum amino acids could be
determined by examining the relative peak heights of the labelled to the
unlabelled protonated molecular ion (MH)"^ without the use of an internal
standard.

The percent of deuteration could then be calculated from (Peak

Height of Labelled) x 100.
To determine the amino acid concentration of both the labelled and the
unlabelled species present in the sample, the addition of the same amino
acid but differently labelled is required.

For example, a patient suffer-

ing from a defect in valine metabolism, namely methylmalonic aciduria, was
fed deuterated valine Dy (50 mg per kg body weight) and samples of blood
and urine were taken at hourly intervals.

The serum and urinary labelled

and unlabelled valine concentrations(Tables 26 and 27) were determined by
the CI-MS method using valine-D^ as the internal standard (Scheme A).

Scheme A - Addition of valine-D^ in direct analysis of D^ and Dy contents
D,
(-^f^) sample

D,

.
x.

Mg % Val-D_ =

(Wt. of DQ) calib.
X 100
Sample Vol

calib.
5z I

Mg % Val-Dy = (D^/DQ) X Mg % DQ, where

»7!

d; = (D_ - f,); and f. = D, contribution
/

/

b

b

D

DD %

X

100

VALINE
If a differently labelled amino acid is not available for use as an
internal standard, it is still possible to determine the concentration of
the labelled and unlabelled amino acid.

In this approach the percent

labelled species is determined first and then the concentration of the
labelled and unlabelled amino acid is determined by the addition of a

Table 26.

Serum valine (DQ) and Valine (DY) levels^ in methylmalonic
aciduria patient (P.B.) after valine (DY) load

Serum Valine Levels (mg %)
Time

% D
Do

D7

(m/e 174)

(m/e 181)

1 1/2

1.77

2.48

58

2

5.53

0.61

19

4

2.48

0.27

10

8

2.67

0.18

7

25

1.85

0.15

8

49

1.74

0.16

8

^50 yl serum, ion-exchange chromatographically cleaned. Valine-D^
(m/e 180) 12.5 n mole used as internal standard. Average of two
determinations.

Table 27. Urine valine (DQ) and valine (DY) levels^ in methylmalonic
aciduria patient (P.B.) during valine (DY) loading test

Urine Valine Levels (mg %)
Time
(hr)

Do
(m/e 174)

% D
D7
(m/e 181)

0

1.03

1 1/2

1.77

0.14

7

3 3/4

1.11

2.99

73

4 1/2

0.48

0.41

46

7

0.93

0.82

47

8 3/4

0.95

0.31

25

0.30

0.12

29

22

-

-

^100 \xl urine, ion-exchange chromatographically cleaned. Valine-D^
(m/e 180) 12.5 n mole used as internal standard. Average of two
determinations.

k n o w n a m o u n t of u n l a b e l l e d a m i n o acid to the s a m p l e .

For e x a m p l e , two

p a t i e n t s s u f f e r i n g from a d e f e c t in t y r o s i n e m e t a b o l i s m w e r e fed tyrosine-D2
(50 m g / k g b o d y w t . ) and s e r u m s a m p l e s w e r e taken at hourly i n t e r v a l s .

The

r a t i o of l a b e l l e d to u n l a b e l l e d tyrosine in the serum w a s determined in the
first experiment

(Table 2 8 ) .

In the second e x p e r i m e n t , 12.5 n moles of

u n l a b e l l e d t y r o s i n e (D ) w a s then added to each sample and the concentration
o
of b o t h l a b e l l e d and u n l a b e l l e d species

(Table 29) w a s determined by

S cheme B .
It s h o u l d b e n o t e d that the d e t e r m i n a t i o n of serum or urine tyrosineD ^ by c l a s s i c a l G C - M S w a s n o t p o s s i b l e since the derivatization of tyrosine
for GC r e q u i r e s acid c a t a l y z e d e s t e r i f i c a t i o n w h i c h led to a p a r t i a l loss
of d e u t e r i u m and our d i - a c e t y l t y r o s i n e d e r i v a t i v e m e t h y l ester w a s not
s u f f i c i e n t l y v o l a t i l e for gas

chromatography.

S c h e m e B - A d d i t i o n of u n l a b e l l e d amino acid in the second experiment
Y
X

T+

R

x

D

o

2nd E x p t .

1st E x p t .
Where X^ =

o

u n d e r n o r m a l i z a t i o n , and

= X _ / X ^ , a n d Ry = Y ^ / Y ^
o' 2
R

M g % of u n l a b e l l e d amino acid (X )

-

X ..
- x
^-^x

M g % of l a b e l l e d amino acid (X2) = M g % X ^ / R ^

W t . of D

o

used

Sample V o l .

X 100

Table 28.

Serum tyrosine (% deuterated) in tyrosinemia patient
(S.T.) during tyrosine-D2 loading test

(hr)

Deuterated Tyrosine^
(%)

0

0

2

31

6

28

24

18

^50 yl serum, deproteinized, derivatized and analyzed by CI-MS.
of two determinations.

Average

Table 29.

Serum tyrosine-DQ and tyrosine-D2 levels in tyrosinemia
patient (S.T.) during tyrosine-D2 loading test^

Time (hr)

Tyrosine-DQ (mg %)

Tyrosine-D2 (mg %)

(m/e 280)

(m/e 282)

0

2.21

0

2

8.64

3.82

6

6.25

2.39

24

22.87

4.87

^50 yl serum. Tyrosine-DQ (m/e 280) 12.5 n mole was used as internal
standard. Average of two determinations.

EXPERIMENTAL

I.

Quantitative Analysis of Amino Acids
Reagents were obtained as follows:

Acetic anhydride from B.D.H.

(Poole, England), methyl alcohol (anhydrous) from Mallinckrodt Chemical
Works (St. Louis, USA), and trimethylphenylammonium hydroxide (TMPH, 0.1 M
in methanol), trifluroacetic acid anhydride from Eastman Kodak Co.
(Rochester, USA).

Pivaldehyde (2,2-dimethyl propanal) was supplied by

K and K Laboratories, Inc. (New York, USA).

Tetramethylammonium hydroxide

(TMAH, 24% in methanol), tetraethylammonium hydroxide (TEAR, 24% in
methanol), acetylacetone, ethylacetoacetate, and molecular sieve (3 A)
were obtained from Matheson Coleman and Bell (New Jersey, USA).

Hydro-

chloric acid in n-butanol (3 N) was supplied by Regis Chemical Co. (Morton
Grove, USA).

Protein amino acids were obtained from Nutritional Bio-

chemicals Corp. (Cleveland, USA) and the stable istopically labelled amino
acid standards; aspartic acid-^%, glutamic acid-^^N, glycine-2, 2-D2,
tyrosine-3,5-D2, valine-D5 and methionine-D3 which had a minimum isotopic purity of 98% were obtained from Merk, Sharp and Dohme (Quebec,
Canada).

Leucine-^%, 99% was provided by Stohler Isotope Chemicals

(California, USA).

The deuterated phenylalanine was prepared according

to the method of Milstein and

Kaufman(83).

Alanine-D3 was synthesized

from methyl iodide-D3 and diethyl acetamidomalonate according to Snyder's
method(8^).

A.

Derivatization of Amino Acid
Solutions of a single amino acid or amino acid mixtures (10-100 n

mole, 2.5 mM in 0.1 N HCl) were transferred to a micro-reaction vial
(0.5 ml capacity) and the appropriate amino acid (25-50 n mole, 2.5 mM in
0.1 N HCl) or amino acid mixture internal standard, labelled with either
deuterium (D) or nitrogen-15 (^^N) was added.

The solution was then

Evaporateci to dryness at 80°C, u n d e r a stream of nitrogen using a heating
block apparatus ( 8 5 ) . a n d followed by derivatization:

(a)

P r e p a r a t i o n of N e o p e n t y l i d i n e Amino A c i d M e t h y l Ester Via Pyrol-

ysis of N e o p e n t y l i d i n e A m i n o A c i d Tetramethy1ammoniurn Salt
T h e dry amino acid w a s redissolved in TMAH or TMPH (10 y l , 0 . 1 M in
m e t h a n o l ) a n d p i v a l d e h y d e (10 Ul) in the presence of molecular sieve 3A
(1 s t i c k ) .

A f t e r a reaction period at room temperature of 15 m i n . , the

m o l e c u l a r sieve was removed a n d the solutions of amino acid ammonium salts
w e r e transferred to the solid probe tip of the mass spectrometer and
evaporated u n d e r reduced p r e s s u r e .

The probe tip was then heated to about

80°C in the ion source region of the mass spectrometer or u n t i l a steady
e v o l u t i o n of P h N ( C H 3 ) 2 at m / e 120 and 121 or N(CH3)3 at m/e 59 and 60 was
o b s e r v e d o n the oscilloscope display of the mass spectrometer.

A f t e r the

pyrolysis conversion of N - p r o t e c t e d amino acid ammonium salt into Np r o t e c t e d amino acid m e t h y l ester was complete (10-30 min.) the probe
temperature was increased gradually u n t i l the amino acid spectrum app e a r e d o n the oscilloscope d i s p l a y .

The msL&s njjtftbiw: of neopentylidine

amino a c i d m e t h y l esters of some selected amino acids are summarized in
T a b l e 30 by both E I and C I mass spectrometry.

(b)

P r e p a r a t i o n of A c e t y l a c e t o n y l Amino A c i d M e t h y l Ester Via Pyrol-

ysis of A c e t y l a c e t o n y l A m i n o A c i d Tetramethylammonium Salt
T h e dry amino acid was redissolved in TMAH or TMPH (10 y l , 0.1 M in
m e t h a n o l ) in the presence of acetylacetone (10 y l ) and molecular sieve 3A
(1 stick).

A f t e r 6 h at r o o m temperature, the molecular sieve was re-

m o v e d a n d the solutions of amino acid ammonium salts were transferred to
the solid probe tip of the mass spectrometer and evaporated under reduced
pressure.

T h e probe tip w a s then heated to about 80°C in the ion source

Table 30.

Mass number of neopentylidene amino acid methyl esters
by EI and CI mass spectrometry

Mass Number, m/ e
Amino Acid
EI (M - C00CH3)+

CI (MH)+

Gly

98

150

Ala

112

172

Val

140

200

Leu

154

214

Met

172

232

Phe

188

248

region of the mass spectrometer or until a steady evolution of PhN(CH3)2
at m/e 120 and 121 or N(CH3)3 at m/e 59 and 60 was observed on the oscilloscope display of the mass spectrometer.

After the pyrolysis conversion

of N-protected amino acid ammonium salt into N-protected amino acid methyl
ester was complete (10-30 min.) the probe temperature was increased
gradually until the amino acid spectrum appeared on the oscilloscope dis«^H"^ iotas
play.

The loaAS nusaeir of acetylacetonyl amino acid methyl esters of some

selected amino acids are summarized in Table 31 by both EI and CI mass
spectrometry.
(c)

Ethylacetoacetyl Amino Acid Methyl Ester Via Pyrolysis of

Ethylacetoacetyl Amino Acid Tetramethylammonium Salt
The dry amino acid was redissolved in TMAH or TMPH (10 yl, 0.1 M in
methanol) in the presence of ethylacetoacetate (10 pl) and molecular
sieve 3A (1 stick).

After a reaction period of 15 min. reflux, the

molecular sieve was removed and the solutions of amino acid ammonium salts
were transferred to the solid probe tip of the mass spectrometer and
evaporated under reduced pressure.

The probe tip was then heated to

about 80°C in the ion source region of the mass spectrometer or until a
steady evolution of PhN(CH3)2 at m/e 120 and 121 or N(CH3)3 at m/e 59 and
60 was observed on the oscilloscope display of the mass spectrometer.
After the pyrolysis conversion of N-protected amino acid ammonium salt
into N-protected amino acid methyl ester was complete (10-30 min.) the
probe temperature was increased gradually until the amino acid spectrum
appeared on the oscilloscope display.

The mass number of ethylacetoacetyl

amino acid methyl esters of some selected amino acids are summarized in
Table 32 by both EI and CI mass spectrometry.

Table 31.

Mass number of acetylacetonyl amino acid methyl esters
by EI and CI Mass Spectrometry

Mass Number, m/e

Amino Acid

EI (M - C00CH3)+

CI (MH)+

Gly

112

172

Ala

126

186

Val

154

214

Leu

168

228

Met

186

246

Phe

202

262

Table 32.

Mass number of ethylacetoacetyl amino acid methyl esters
by EI and CI mass spectrometry

Mass Number, e/e
Amino Acid
EI (M - C00CH3)+

CI (MH)+

Gly

142

202

Ala

156

216

Val

184

244

Leu

198

258

Met

216

276

Phe

232

292

(d)

Preparation of N-acetyl Amino Acid Methyl (or Ethyl) Ester Via

Pyrolysis of Acetyl Amino Acid Tetramethyl or Tetraethyl Ammonium Salt
The dry amino acid was redissolved in TMAH (10 yl, 0.1 M methanol),
TMAH (10 yl, 0.1 M ethanol), TEAH (10 yl, 0.1 M methanol), or TEAH (10 yl,
0.1 M ethanol) in the presence of acetic anhydride (10 yl) and molecular
sieve 3A (1 stick).

After 2 hours at room temperature, the molecular

sieve was removed and the solutions of amino acid ammonium salts were
transferred to the solid probe tip of the mass spectrometer and evaporated
under reduced pressure.

The probe tip was then heated to about SO'^C in

the ion source region of the mass spectrometer or until a steady evolution
of PhN(CH3)2 at m/e 120 and 121 or N(CH3)3 at m/e 59 and 60 was observed
on the oscilloscope display of the mass spectrometer.

After the pyrolysis

conversion of N-protected amino acid ammonium salt into N-protected amino
acid methyl ester was complete (10-30 min.) the probe temperature was increased gradually until the amino acid spectrum appeared on the oscilloscope display.

The mass number of N-acetyl amino acid methyl (or

ethyl) esters of some selected amino acids are summarized in Table 33 by
both EI and CI mass spectrometry.

(e)

Preparation of N-acetyl Amino Acid Methyl (or Ethyl) Ester

using Acetic Anhydride - Methanol (or Ethanol)
The dry amino acid was redissolved in a mixture of acetic anhydride
(20 yl) and methanol or ethanol (100 yl) in the presence of molecular
sieve 3A (1 stick).

After 5 min. to 30 min. at 100°C, the molecular

sieve was removed and the solutions were transferred to the solid probe
tip of the mass spectrometer and evaporated under reduced pressure.

The

probe tip was then heated gradually (80-200°C) until the amino acid
spectrum appeared on the oscilloscope display.

The CI mass spectra of

Table 33.

Mass number of N-acetyl amino acid derivatives of methyl
and ethyl esters by EI and CI mass spectrometry

Methyl Ester (m/e)
Amino acid

EI (M-C00CH3)+

CI (MH)+

Ethyl Ester (m/e)
EI (M-C00CH3)+

CI (MH)+

Gly

72

132

86

146

Ala

86

146

100

160

Val

114

174

128

188

Leu

128

188

142

202

Met

146

206

160

220

Phe

162

222

176

236

N-acetyl amino acid methyl (or ethyl) esters were recorded and the mass
number of N-acetyl amino acid derivatives was determined (Table 33).

(f)

Preparation of N-trifluoroacetyl Amino Acid n-Butyl Ester(Q^)

The dry amino acid was sonicated with 3N HCl/n-butanol (150 yl) and
heated for 15 min. at 100°C, and the solution was then evaporated to
dryness with nitrogen.

A solution of trifluoroacetic anhydride-dichloro-

methane (1:3 v/v, 100 ul) was then added into the reaction vial and the
vial was tightly capped, sonicated (1 min.) and heated at 150°C for 5 min.
An aliquot of the solution (5 Ul) was used for gas chromatographic
analysis and aliquots of 10-15 ]il were transferred to the solid probe
tip of the mass spectrometer and evaporated under reduced pressure.

The

probe tip was then heated gradually (80-200°C) until the amino acid
spectrum appeared on the oscilloscope display.

The mass number of N-

trifluoroacetyl amino acid n-butyl esters of some selected amino acids
are summarized in Table 34.

For gas chromatography, an EGA column (0.325%

on 80/100 mesh a.w. HT Chromosorb C, 6 in x 1/2 in I.D., U-glass) was used
for the separation of the N-acetyl amino acid derivatives.

The gas

chromatograph used was a Tractor MT 220 model equipped with a Coulson
nitrogen detector.

The GLC instrumental setting and parameters are shown

in Table 35.

B.

Preparation of Plasma Amino Acid
Plasma (50 yl) was transferred to a centrifuge tube and a standard

solution of labelled amino acid (12.5 n mole, 5 yl of 2.5 mM solution in
0.1 N HCl) was added, followed by absolute alcohol (200 yl) .
tion was shaken and then centrifuged (5 min., 2600 rev/min.).

The soluThe

supernatant was transferred to a reaction vial and evaporated to dryness
under a stream of dry nitrogen.

The dry residue was then redissolved in

mixture of acetic anhydride (20 yl) and methanol (100 yl) in the presence

Table 34.

Mass number of N-trifluoroacetyl amino acid n-butyl ester
by CI mass spectrometry

Mass Number (m/e)
Amino Acid

—
(MH)+

Gly

228

Ala

242

Val

270

Leu

284

Met

302

Phe

318

Table 35.

Gas Chromatograph conditions for the separation of Ntrifluoroacetyl amino acid n-butyl ester using Coulson
Electrolytic Conductivity Detector

Column

0.35 w/w7o EGA on 80/100 Mesh A. W,
H. T. Chromosorb G.^

Helium flow ml/min
Carrier
Pyrolyzer

60
10

Hydrogen flow, ml/min
Pyrolyzer (Detector)

50

Pyrolyzer temperature, °C

820

Initial temperature, °C
EGA

90
5

Programmed temperature, °C/min
Final temperature, °C

235

Inlet temperature, °C

210

Chart speed, in./min

0.5

^EGA = Ethylene Glycol Adipate
H. T. = Heat treated at 550 C for 16 hours

of molecular sieve 3A (1 stick).

After 5 min. at 100°C heating period, an

aliquot of 10 ]il solution was transferred to a probe tip sample holder,
evaporated under vacuum, and admitted through a direct insertion probe
for MS analysis.

The probe tip was then heated slowly in the ion source

region of the mass spectrometer (80-180°C) until the amino acid spectrum
appeared on the oscilloscope display.

The mass spectrum of N-acetyl amino

acid methyl esters was then recorded with a background spectrum being
recorded at 50°C.

The mass number of the N-acetyl amino acid methyl

ester and their corresponding internal standard used in the study of
ratio determination by CI-MS are summarized in Table 36.

The peak height

ratio of unlabelled to labelled amino acid was thus calculated.

C.

Preparation of Amino Acids from 5 yl Dried Blood Sample
The whole blood (5 Ul, heparinized) was spotted on filter paper

(Guthrie blood test paper) and dried at 100°C for 10 min. and was then
stored in the desiccator (anhydrous CaSO^, indicating desiccant) before
use.

The dried blood spot (5 yl) was punched out (with 4 mm diameter

cork puncher) and placed in a reaction vial, aqueous ethanol (200 yl, 80%
v/v) and labelled amino acid (12.5 n mole, 5 yl of 2.5 mM solution in
0.1 N HCl) were added.

The vial was capped and the contents ultra-

sonically mixed* for 5 min.

The filter paper disc, which retains the

denatured protein, was removed with tweezers and the solution was evaporated to dryness with nitrogen at 80°C.

The residue was then redissolved

in a mixture of acetic anhydride (10 yl) and methanol (50 yl) in the
presence of molecular sieve 3A (1 stick).

After 5 min. at 100°C heating

period, an aliquot of 10 yl was transferred into a probe tip sample
holder, evaporated under vacuum, and admitted through a direct insertion
probe for MS analysis.

The probe tip was then heated slowly in the ion

Table 36.

Mass number of N-acetyl amino acid methyl esters used
for ratio determination by CI mass spectrometry

Derivative Type
Amino

Mass Number (MH+,m/e)
Unlabelled

Labelled

Internal Standard
(D or N-15)

Acetyl

Methyl

Gly

Mono-

Mono-

132

134

Gly - D2

Ala

M

II

146

149

Ala - D3

II

174

180

Val - ^6

II

188

189

Leu -

Val
Leu & lie

M

Asp

It

Di-

204

205

Asp

II

Mono-

206

209

Met

Met

-

-

Glu

M

Di-

218

219

Glu - 1 %

Phe

II

Mono-

222

227

Phe

M

245

246

Lys -

M

280

282

Tyr - ^2

Lys
Tyr

Din

-

%

source region of the mass spectrometer until the amino acid spectrum
appeared on the oscilloscope display.

The mass spectrum of N-acetyl amino

acid methyl esters \^as then recorded at 80 - 180°C with a background
spectrum being recorded at 50°C.

The mass number (Table 1) of the N-

acetyl amino acid derivatives and their corresponding internal standard
were measured and the peak height ratio of the unlabelled to labelled amino
acid was determined.

The effect of the drying process on blood amino

acid content was determined by the following experiments:

Whole blood was

supplemented with glycine, alanine and phenylalanine to produce concentration of 0 (control), 5 and 10 n mole per 5 yl dried blood spot.

A

fixed amount (10 n mole) of labelled internal standards, e.g., glycine-D2,
alanine-D3 and phenylalanine-D^ was then used for each analysis.

The peak

height ratios for glycine (m/e 132 / 134), alanine (m/e 146 / 149) and
phenylalanine (m/e 222 / 227) were determined from the mass spectra.

The

analytical results showed that the drying procedure (100°C/10 min) did
not change the blood amino acid content.
*

CAUTIONS :

Criteria for good sonication of samples:

(1) Reaction

vial should be thin-walled type (1 mm thick) and the inside diameter
(available space) should be at least 6 mm; (2) The sample reagent containing filter paper disc should be submerged under the water surface
level of the ultrasonic unit during mixing and extraction; and (3) A good
visible agitation both inside and outside the reaction vial is essential.

D.

Preparation of Amino Acids from Dried Blood Spotted on Guthrie Test
Paper
The whole blood spot (ca. 10 mm - 15 mm) was punched out discs (4 mm

dia. with 4 mm stainless cork puncher) and each of them was placed in a
reaction vial, aqueous ethanol (200 yl, 80% v/v) and the corresponding

labelled amino acid (12.5 n mole, 5 yi of 2.5 mM solution in 0.1 N HCl)
it» ,
were added.
5 min.

The vial was capped and the contents ultraso^cjfally mixed for

The filter paper disc, which retains the denatured protein, was

removed with tweezers and the solution was evaporated to dryness with
nitrogen at 80°C.

The residue was then redissolved in a mixture of

acetic anhydride (10 Ul) and methanol (50 yl) in the presence of molecular
sieve 3 A (1 stick).

After 5 min. at 100°C heating period, an aliquot of

10 yl was transferred into a probe tip sample holder, evaporated under
vacuum, and admitted through a direct insertion probe for MS analysis.
The probe tip was then heated slowly in the ion source region of the mass
spectrometer until the amino acid spectrum appeared on the oscilloscope
display.

The mass spectrum of N-acetyl amino acid methyl esters was then

recorded at 80 - 180°C with a background spectrum being recorded at 50°C.
The peak height of the unlabelled and the labelled amino acids were
measured and the peak height ratio was calculated for glycine (m/e 132
vs. m/e 134), alanine (m/e 146 vs. m/e 149), valine (m/e 174 vs. m/e 180)
and phenylalanine (m/e 222 vs. m/e 227).

The results of spectral

analysis showed that no detectable blood amino acids separation occurred
within the 10 to 15 mm spots.

For quantitative analysis, the amount

(volume) of blood in 4 mm disc should be determined.

For this purpose,

the following experiments were carried out.
E.

Calibration of 4 mm Dried Blood Disc from Guthrie Test Paper Using
4 mm Stainless Puncher
For the determination of blood volume in 4 mm discs punched off with

4 mm stainless cork puncher, three calibration experiments on the blood
spot samples were conducted:

(1) the calibration of known size (4 ram)

and known volume (5 yl) blood spots containing 2 - 20 mg7o phenylalanine;

(2) the calibration of known size (10-15 mm) but unknown volume blood
spots containing 4 - 1 0 mgJo phenylalanine; and (3) the calibration of
known blood phenylalanine concentration (10 mg7o) from the blood spotted
on Guthrie Test paper of 5 yl (equivalent to the size of 4 ram) or of 10 15 mm (close to the circled ring as instruction given on the Guthrie Test
paper) (Fig. 25).
In the first experiment, each 4 ram blood spot containing 5 yl blood
run in duplicate was extracted with 200 yl ethanol (80%) containing
12.5 n mole of Phe-D^ (5 yl of 2.5 raM solution in 0.1 N HCl), and the
extract was dried with nitrogen, redissolved in a mixture of acetic
anhydride-methanol (10 yl + 50 yl) and heated at 100°C for 5 rain. The
solution (10 yl) was transferred into a probe tip sample holder, evaporated under vacuum and admitted through a direct insertion probe for MS
analysis.

The results of this experiments showed a linear concentration

curve for blood phenylalanine plotted as peak height ratio (m/e 222 for
phenylalanine and m/e 227 for phenylalanine-D5) on Y-axis vs. a range of
phenylalanine level (2-20 mgX) on X-axis.

In the second experiments, the

same 4 mm puncher was used to punch out discs from the large blood spots
(10-15 mm) containing 4 mg7o, 6 mg7o, 8 mg7o and 10rag7ophenylalanine on
Guthrie Test paper (run in duplicate).

The disc taken within the large

blood spots were then processed individually as previously described for
MS analysis.

Again, a linear curve for blood phenylalanine concentration

was obtained when the average peak height ratio of unlabelled to labelled
phenylalanine (ra/e 222 vs. 227) was plotted against phenylalanine
concentration.

In the third experiments, 4 mm blood discs from 5 yl

blood and 4 mm blood discs from 10 - 15 mm blood spots were individually
analyzed for the peak height ratio when a fixed amount of Phe-D^ (12.5 n
mole, 5 yl of 2.5 mM solution in 0.1 N HCl) was used for each analysis

( A )

4 mm punch

4 mm punch

Blood spot

Blood spot

o o
o o
F i g . 25.

( B )

Co)

Calibration of 4 mm (dia.) dried blood disc sample
from Guthrie Test Paper using (A) 5 yl blood spot,
and (B) 10 - 15 mm size blood spot.

in total of eight determinations.

The MS procedure was the same of the

two previous experiments and the spectral data, e.g., peak height ratio
of phenylalanine (m/e 222 vs. 227) was averaged from four sample runs for
each group, e.g., 4 mm and 10 - 15 mm blood samples.

The results of these

experiments showed that the 4 mm disc, punched out with a 4 mm stainless
puncher from the 10 - 15 mm blood spots of Guthrie Test paper, contains
a blood volume of 5.5 Ul + 0.2.

F.

Mass Spectrometry of Amino Acids
The CI mass spectra were recorded on a Dupont 21-491 B mass spectro-

meter modified for operation in the chemical ionization (C.I.) mode.
reagent gas used was isobutane at pressure between 0.5 - 1.0 Torr.

The
The

source temperature was maintained at 200°C and the probe temperature was
varied from ambient to 200°C.

The energy of the electron beam was 70 eV.

The block voltage was 1400 V d.c. and the repeller plates were maintained
at the block voltage.

Mass spectra of amino acid derivatives were re-

corded from 80 - 200°C with a background spectrum being recorded at 50°C.
The spectra shown in the plots were reconstructed from the combined
spectra obtained at different solid probe temperatures after subtracting
the background spectrum.

The ^^c isotope ratio and the CI peaks due to

the isobutane have been left out of the reconstructed plots to allow
simpler presentation of the results.

The mass number (MH+) of the

volatile amino acid derivatives and their corresponding internal standard
used for ratio determination by CI-MS are presented in Tables previously.
The concentrations of the individual amino acids were determined by
comparing the average spectral peak height of the unlabelled amino acid
with that of the corresponding labelled amino acid and averaging the results from the five measurements.

The EI mass spectra of amino acid derivatives were recorded on a
Quadruple EAI 300 mass spectrometer. The source temperature was maintained at 200°C and the probe temperature was varied from ambient to
200°C.

The energy of the electron beam was 70 eV.

In all cases, the

sample was admitted through a direct insertion probe.

The EI mass

spectra of amino acid derivatives were recorded from 80 - 250°C and the
characteristic amine fragment ion (M-COOCH3) of unlabelled and labelled
(internal standard, if used) amino acids was used for ratio determination.
For example, N-acety-phenylalanine-D^ and internal standard N-acetylphenylalanine-D^ methyl esters were recorded at m/e 162 and 167, respectively.

G.

Quantitative Calibration and Calculation
Calibration curves of a single amino acid and of amino acid mixtures

were determined by comparing the protonated molecular ion peak height
(CI) or the amine fragment ion peak height (EI) of a concentration range
of unlabelled amino acids with that of the appropriate isotopically
labelled amino acids.

This was done by a manual method in which five

mass spectral scans were recorded on UV sensitive chart paper and the
mean peak height ratios from these five measurements were calculated.
Blood amino acid concentrations were calculated as follows:

^ A^t
mg7o

)

— —
. A A \
1 s a m
( — ^ ^ ^ — ) calibration
A A*

X
p

(Wt. of A A)
:;
^
l e
volume
^

calibration ^ ^QQ

Where (A A / A A^) = mean peak height ratio of unlabelled to labelled
amino acid,
A A^ = labelled amino acid as internal standard, if

amino

acids are used, correction should be made for the natural
abundance of 13c (1.08%) and D (0.016%) isotopes, and

(f) = mean peak height ratio of unlabelled to labelled of internal
standard.

H.

Mass Spectrometry of Stable Isotopically Labelled Amino Acids for
Metabolic Studies
The subject was fed orally 50 mg tyrosine-D2 or valine-Dy per kg body

weight.

Plasma sample (50 yl) taken at the time intervals indicated were

deproteinized with 200 yl ethanol by centrifugation and derivatized with
a mixture of acetic anhydride-methanol (10 yl + 50 yl) reagent at 100°C
for 5 min.

Aliquot of 10 yl was transferred into a probe tip sample

holder, evaporated under vacuum and admitted through a direct insertion
probe for direct CI mass spectrometry.

The relative peak heights of the

protonated molecular ions for unlabelled and labelled tyrosine (m/e 280
for tyrosine-Do and m/e 282 for tyrosine-D2) and valine (m/e 174 for
valine-DQ, m/e 180 for valine-D5 and m/e 181 for valine-Dy) were measured
and averaged and the per cent deuterium content was calculated.

Total

concentration of the amino acids were determined by adding 12.5 n mole
(5 yl of 2.5 iriM solution in 0.1 N HCl) of labelled tyrosine-D2 or valineD5 standard or of unlabelled (DQ) acid standard as required to the plasma
samples and repeating the derivatization process and the mass spectral
analysis.

I.

Analysis of Amino Acids in Urine, Saliva and Amniotic Fluids
Amniotic fluid, saliva and urine samples (50 - 100 yl) were added to

the reaction vials, and the appropriate labelled amino acid standards
(12.5 n mole, 5 - 10 yl of 2.5 mM solution in 0.1 N HCl) were added.
The solution was then evaporated to dryness under nitrogen at 80°C.

The

dry amino acid residue was redissolved in a mixture of acetic anhydride
(10 - 20 yl) and methanol (50 - 100 yl) in the presence of molecular

sieve 3A (1 stick) and then derivatized at 100°C for 5 min. and transferred
to a sample holder, evaporated under vacuum prior to mass spectrometric
determination.

The relative peak height ratio of the protonated molec-

ular ions of unlabelled to labelled amino acids, for example, glycine
(m/e 132 vs. 134), alanine (m/e 146 vs. 149), valine (m/e 174/180), etc.
were determined and calculations for each amino acid concentration were
were followed.

J,

Preparation of Peptide or Protein Acid Hydrolysates for Amino Acid
Analysis by Mass Spectrometry and Ion-exchange Chromatography
Peptide sample (5 mg) of Asp-Phe, Gly-Met-Phe, Asp-Gly-Met-Phe and

Met-Asp-Val-Glu-Leu-Phe were weighed into a reaction tube and 2 ml of
6 N HCl were added.

After flushing with nitrogen, the tube was capped

and the contents were heated for 22 h at 110°C.

After removal of the

solvent in vacuo, the residue was redissolved in distilled water (2 ml)
and an aliquot (1 ml) of the hydrolysates was used for ion-exchange
chromatography.

For mass spectrometric analysis, the appropriate D or

l^N labelled amino acid standards of 12.5 n mole (5 Pi of 2.5 mM solution in 0.1 N HCl) were added into the hydrolysate (2 - 8 yg) in duplicate
and the mixture was then dried under nitrogen at 80°C.

The dry amino

acid residue was redissolved in a mixture of acetic anhydride-methanol
(10 + 50 yl) reagent in the presence of molecular sieve 3A (1 stick) and
the solution was heated at 100°C for 5 min.

Aliquot of 10 yl of the

solution was then transferred to a sample holder, evaporated to dryness
under reduced pressure, and admitted through a direct insertion probe
for MS analysis.

The probe tip was then heated slowly in the ion source

region of the mass spectrometer until the amino acid spectrum appeared on
the oscilloscope display.

The mass spectrum of N-acetyl amino acid

methyl esters was recorded at 80 - 180°C with a background spectrum being

recorded at 50°C.

T h e p e a k height of the unlabelled and the labelled

amino acid w e r e measured and the peak height ratio for each amino acid
w a s c a l c u l a t e d , for e x a m p l e , aspartic acid (m/e 204 v s . 205), glutamic
acid (m/e 218 v s . 219), leucine (m/e 188 v s . 189) and methione
(m/e 2 0 6 / 2 0 9 ) , e t c .

The amino acid residue of each peptide was calculated

in terms of w e i g h t basis or mole basis using the formula described in
Procedure G .
For ion-exchange chromatography, the aliquot (30-70 y g ) was dried
w i t h rotary evaporator and taken up in 2 ml of pH 2.2 c i t r a t e buffer and
analyzed on B e c k m a n M o d e l 120 B amino acid analyzer.

K.

Comparative Analysis of Plasma and Blood Phenylalanine using Mass
S p e c t r o m e t r y , Ion-exchange Chromatography and Gas Chromatography
For mass spectrometric analysis of blood phenylalanine, whole blood

(5 \ll) w a s spotted on filter paper (Guthrie test paper) and dried at
100°C for 10 m i n .

The whole blood spot was then punched out using a 4 m m

stainless cork puncher and placed in the reaction vial.

The amino acids

w e r e extracted with 200 y l alcohol (80%) containing the appropriate
a m o u n t of Phe-D3 (12.5 n m o l e , 5 y l of 2.5 mM solution in 0.1 N H C l ) by
sonication for 5 m i n . and derivatized with a mixture of acetic anhydridem e t h a n o l (10 + 50 y l ) at 100°C for 5 m i n . and analyzed by direct CI mass
spectrometry (mass number m/e 222 v s . m/e 227) and EI-MS (m/e 162 v s .
m/e 167).

Plasma (50 y l ) of the same blood sample was deproteinized

w i t h alcohol (200 y l ) containing the internal standard Phe-D5 (25 n m o l e ,
10 y l of 2.5 m M in 0.1 N H C l ) and the supernatant was treated according
to P r o c e d u r e B .

Plasma (100 y l ) of the same blood specimens was de-

proteinized with 37o sulfosalicylic acid and was analyzed for free amino
acid levels by ion-exchange chromatography based on a standard method of

Ill

Beckman Model 120 B Amino Acid Analyzer.

For gas chromatography, plasma

(50 yl) was deproteinized first with alcohol (200 lil) and the supernatant
containing the internal standard (a-amino caprylic acid, 25 n mole, 10 \il
of 2.5 mM in 0.1 N HCl) was dried with nitrogen and the residue was derivatizedC^^jS^).

The derivatization procedure involves a direct esterifi-

cation and acylation.

For this purpose, the dry residue was first

sonicated with HCl/n-butanol (3 N, 150 Ul) and heated for 15 min. at
100°C.
80°C.

The solution was then evaporated to dryness with nitrogen at
For acylation, a solution of trifluoroacetic anhydride-dichloro-

methane (1: v/v, 100 PI) was then added, sonicated and heated for 5 min.
at 150°C.

Aliquot of 5 yl solution was injected into an EGA column

(0.325% on 80/100 mesh a.w. HT Chromosorb G, 6 in x 1/2 in I.D., U-glass)
of a Tractor MT 220 gas chromatograph equipped with a Coulson nitrogen
detector.

Initial temperature, 80°C, program 5°/min.

Helium flow

(carrier) was maintained at 60 ml/min., and the detector pyrolyzer at
10 ml/min.

Hydrogen flow in the pyrolyzer was 50 ml/min., and the

pyrolyzer temperature was 820°C.

L.

Comparative Analysis of Blood Spot Using Mass Spectrometry and
Guthrie Test
Blood spot samples were first screened by Guthrie bacterial inhibi-

tion

and the phenylketonuric (PKU) positive samples were

subjected to mass spectrometric analysis.
experiments:

The MS analysis included two

(1) the calibration of known blood spots (Guthrie Test

standard, 5 yl) containing 2 - 20 mg% phenylalanine as reference; and
(2) the analysis of Guthrie Test blood spots (10-15 mm).

In the first

experiments, each 5 yl blood spot run in duplicate was extracted with
ethanol (200 yl, 80%), and the extract was dried with nitrogen.

redissolved in a mixture of acetic anhydride-methanol (10 + 50 yl) and
derivatized in the presence of 12.5 n mole of Phe-D^ (5 yl of 2.5 raM in
0.1 N HCl)at 100°C for 5 min. followed by MS analysis.

The results of

these experiments showed a straight line relationship between the blood
phenylalanine level and the spectral data of peak height ratio (m/e 222
for Phe vs. m/e 227 for Phe-D5).

In the second experiments, the large

blood spots (10-15 mm) on Guthrie Test paper were punched out 4 mm discs
(5.5 yl blood volume) from the center or off the center.

The discs, run

in duplicate, were sonicated with 80% ethanol (200 yl) containing 12.5 n
mole (5 yl of 2.5 mM in 0.1 N HCl) Phe-D5.

The amino acid extracts were

then dried under nitrogen at 80®C and derivatized with a mixture of
acetic anhydride-methanol (10 + 50 yl) in the presence of molecular sieve
3A (1 stick) at 100°C for 5 min.

Aliquots of 10 yl were then transferred

to a sample holder, evaporated to dryness under vacuum, and admitted
through a direct insertion probe for MS analysis.

The mass spectrum of

N-acetylphenylalanine methyl ester was then recorded at 80 - 180°C with
a background spectrum being recorded at 50°C.

The peak height of the un-

labelled and the labelled phenylalanine derivative (m/e 222 and m/e 227)
were measured and the peak height ratio, m/e 222 vs. 227, and phenylalanine concentration were calculated.
A number of 'old' filter paper samples were also analyzed by MS and
the analytical results were compared with Guthrie Test for phenylalanine
screening program dated 1975.

II.

Quantitative Analysis of Fatty Acids
Laurie acid (Ci2:o). myristic acid (C14.0), palmitic acid (CI^.Q)

and stearic acid (Ci8:0) ^^^^ obtained from Sigma Chemical Co.,
(St. Louis, USA), phytanic acid (3,7,11,15-tetramethylhexadecanoic acid)

and BF3-methanol reagent (14% w/v) from Applied Science Lab., Inc. (State
College, USA); acetic anhydride-D^ and D2SO4 from Merck Sharp and Dohme
(Montreal, Canada) and deuterium oxide from the Atomic Energy Commission
(Lucas Heights, Australia).

A,

Gas Chromatography of Fatty Acids
The fatty acid composition

of a standard fatty acid mixture

(w/w7o)

(Cl2:0> ^14-0, Ci6:0> Ci8:0 1:1:2:1.5 w/w) was determined by gas chromatography of their methyl ester derivatives using BF3-methanol reagent.
The mixture in chloroform was evaporated to dryness with nitrogen and
BF3-methanol reagent (50 yl) was added to the dry residue and heated at
100°C for 5 min.

Aliquots of the solution (3 yl) were analyzed on a

Varian Series 2700 G.C. using a 6 ft x 1/8 in. stainless steel Apiezon N
column on 80/100 mesh chromosorb W (AW/DMCS treated).

A helium flow of

30 ml/min. and a 10°C/min. temperature program from 160°C was used.

B.

Preparation of a-Deuterated Fatty Acid Standards
Deuterium labelled saturated fatty acids were prepared by a modifica-

tion of van Heyningen's technique(75).

A standard solution of fatty acid

(0.2 mg of Ci2:0 to Ci8:0 or phytanic acid) in chloroform (0.2 ml) was
transferred to a screw top reaction vial (ca. 2 ml capacity) and the
solvent was removed with nitrogen.

Acetic anhydride-D^ (100 yl), D2O

(100 yl) and conc. D2SO4 (25 yl) were then added.
and then heated at 150 - 160°C for 20 h.

The vial was capped

The vial was then cooled and

vented and the labelled fatty acids were extracted into hexane (400 yl),
washed with H2O (400 yl) and dried.
n.ined by mass spectroscopy.

Deuterium incorporation was deter-

The fatty acid standards showed a minimum

isotopie purity of 86% D in the two a-positions, e.g., Ci2:0 (93%), C14.0
(91%), Ci6:0 (88%), Ci8:0 (86%) and phytanic acid (91%).

C. M a s s S p e c t r o m e t r y of P u r e F a t t y A c i d
T h e C I mass spectra w e r e recorded o n a Dupont 21-491 B mass
s p e c t r o m e t e r in the c h e m i c a l ionization (CI) mode using isobutane at 0.5 1.0 T o r r .

T h e i n s t r u m e n t a l conditions used w e r e the same as for amino

a c i d a n a l y s e s e x c e p t that the m a s s spectra w e r e recorded at 20°C intervals
f r o m 80 - 180°C.
To a r e a c t i o n v i a l w a s added a single fatty acid (Cj^2-0i ^14* 0>
^16:0J ^18:0°^ p h y t a n i c a c i d 5 y g ) dissolved in chloroform (10 y l ) or a
fatty a c i d m i x t u r e (5 P g of each acid dissolved in 10 y l chloroform for
e a c h fatty a c i d component p r e s e n t ) a n d a deuterated internal standard
(CI2:0-D2, C I 4 : 0 - D 2 , C I 6 : 0 - D 2 , Ci8:0-D2 O^ phytanic a c i d - D 2 , 5 Pg/lO m l
c h l o r o f o r m ) a n d the solution was transferred to a sample h o l d e r , evapor a t e d to dryness u n d e r v a c u u m , and admitted through a direct insertion
p r o b e for M S a n a l y s i s .

T h e mass number of free fatty acid and their cor-

r e s p o n d i n g i n t e r n a l standard by CI-MS are summarized in Table 3 7 .

D.

F r e e F a t t y A c i d A n a l y s i s in Dried Blood Spot
To a r e a c t i o n v i a l w a s added a chloroform-methanol mixture (400 y l ,

2 : 1 v / v ) , the appropriate deuterium labelled fatty acid standard (2 y g in
10 y l c h l o r o f o r m ) , a n d the dry blood spot (4 m m filter paper d i s c , 5.5 y l
blood).

I t w a s then u l t r a s o n i c a l l y m i x e d for 5 m i n . and the filter paper

disc w h i c h retains the protein and other chloroform-methanol insoluble
components w a s r e m o v e d w i t h tweezers.

The solution was then evaporated

to dryness w i t h n i t r o g e n at 80°C and the dry residue was redissolved in
c h l o r o f o r m (25 y l ) .

A n aliquot (10 y l ) of the solution was transferred

to a p r o b e tip a n d m o s t of the solvent was evaporated under vacuum and
the dry residue a n a l y z e d by direct mass spectrometry for C]^2:0
at m / e 2 0 1 to m/e 3 1 3 .

^20:0

Table 37.

Mass number of free fatty acid used for ratio
determination by CI mass spectrometry

Mass Number (MH+,m/e)
Fatty Acid
Unlabelled / Labelled

Internal Standard
(D)

^12:0

201

/

203

^12:0

^14:0

229

/

231

^14:0 - »2

257

/

259

^16:0

•^18:0

285

/

287

^18:0 - D2

<^20:0
(Phytanic acid)

313

/

315

^20:0 - »2

-

-

E. Quantitative Calibration and Calculation
Calibration curves of fatty acid mixtures

phytanic

acid (C20:o) "were determined for a concentration range of 0 - 2.0 yg.
To a reaction vial was added a chloroform-methanol mixture (400 yl,
2:1 v/v), the appropriate deuterated internal standard (1.0 yg in 5 yl
chloroform) and the free fatty acids (0 - 2.0 yg in chloroform, 1 yg/5 yl).
It was then sonicated for 5 min. and the content was concentrated to 25 30 yl.

An aliquot of 10 yl of the solution was transferred to a probe

tip and the solvent was evaporated under vacuum and admitted to the mass
spectrometer.

The peak height ratios were determined by comparing the

protonated molecular ion peak height of the unlabelled with the corresponding labelled fatty acid, e.g., for C]^2;0 ^^

^^^ ^^^

^14;0 ^^

m/e 229/231, etc., and averaging the results from five measurements.
A calibration curve for a blood fatty acid was determined using
labelled stearic acid.

This was done by adding a chloroform-methanol

mixture (400 yl, 2:1 v/v), the appropriate deuterated stearic acid
(CI8-0"^2)

^^ ^^ ^^ chloroform), and the dry blood spot (20 yl,

dried at 100°C/10 min.) to a reaction vial.

The blood fatty acids were

then extracted by sonication (5 min.) and the solution was concentrated
after the removal of the paper disc.

An aliquot (10 yl) of the solution

(25-30 yl) was transferred to a probe tip and the solvent was evaporated
under vacuum and admitted to the mass spectrometer.

The peak height

ratios were determined by comparing the peak height of the unlabelled
stearic acid with the labelled stearic acid (m/e 285/287) and averaging
the results from five measurements.
Blood fatty acid concentrations were calculated using the same
formula as described in the amino acid section G (see page 107).

F.

Analysis of Free Phytanic Acid in Blood
(a)

Dry Blood:

To a reaction vial was added a chloroform-methanol

mixture (400 yl, 2:1 v/v), 2.5 \ig phytanic acid-D2 (in 5 yl chloroform),
and the dry blood spots (2 disc, 4 mm dia. containing 5.5 yl each).

It

was then sonicated for 5 min. and the filter paper discs were removed.
o

The solution was then concentrated to 25 - 30 yl with nitrogen at 80 C.
An aliquot (10 yl) of the solution was transferred to a probe tip and was
evaporated under vacuum and the dry residue analyzed by direct mass
spectrometry.

The peak height ratios were determined by comparing the

peak height of the unlabelled to corresponding labelled phytanic acid
(m/e 313/315) and averaging the results from five measurements.

Blood

phytanic acid concentrations were calculated as previously described for
fatty acids.
(b)

Plasma and Serum:

To a reaction vial was added 2.5 yg phytanic

acid-D2 (in 5 yl chloroform) and the solvent was evaporated with nitrogen
at 80°C followed by the addition of 100 yl acetone and 10 yl plasma or
serum.

The content was sonicated for 1 min. and evaporated to dryness

with nitrogen at 80°C.

The dry residue was redissolved in a chloroform-

methanol mixture (100 yl, 2:1 v/v) and sonicated again for 5 min.

The

solution was then concentrated to 25 - 30 Ul and an aliquot of 10 yl was
transferred to a probe tip and the solvent was evaporated under vacuum
and the dry residue analyzed by direct mass spectrometry for phytanic
acid (m/e 313).

III.

Quantitative Analysis of Cholesterol
Cholesterol was obtained from the British Drug Houses, Ltd. (Pool,

England).

Cholesteryl palmitate and cholesteryl stearate were supplied

by Applied Science Lab., Inc. (State College, USA).

A.

Preparation of Deuterium Labelled Cholesterol Standard
The deuterated cholesterol was prepared using a variation on the

method of Diekman and
and

Malhotra(S8)

Djerassi(76)^

Dauben and Eastman(87)j and Ringold

, A4-cholesten-3-one (200 mg), +-butanol-OD (7 ml) and

potassium +-butoxide (500 mg) were stirred under nitrogen for 3 hours.
The mixture was cooled and acidified with a mixture of acetic acid -QD^
and D2O, extracted with CH2CI2 and the organic layer washed (water, 2x),
dried (MgS04) and evaporated.

T.l.c. showed a mixture of A4- and A5-

cholesten-3-ones (approx. 1:1) which were separated by prep, t.l.c.
(Si02; ethyl acetate/60-80 pet. ether (1:4)).

The zone corresponding to

A4-cholesten-3-one (90 mg) isopropenyl acetate (1.0 ml), D2SO4 (10 yl)
were refluxed for 20 min.

Sodium acetate (50 mg) was added to the solu-

tion and the liquid removed under vacuum.

The solid residue was washed

with chloroform (3x, 5 ml) and the washings decanted and evaporated.

The

residue (90 mg) was taken up in methanol and the solution stirred at room
temperature during the addition of NaBD^ (100 mg in 5 ml methanol).

The

solution was refluxed for 30 min., cooled and hydrochloric acid (3 ml,
2N) added dropwise, and then distributed between ethyl acetate and
water.

The organic layer was washed with H2O (2x) dried and evaporated

and the product crystallized from methanol (30 mg, m.p. 143-146).

The

CI mass spectral analysis showed a mixture of species D^ - D5 with D4
predominating, e.g., Di (4%), D2 (12%), D3 (24%), D4 (32%) and D5 (28%).

B.

Preparation of Deuterium Labelled Cholestryl Stearate Standard
The deuterated cholesterol esters, e.g., cholestryl stearate and

cholesteryl palmitate, were prepared using the method of Fieser and
Schneider(80).

Recrystallized stearic acid (20 mg) in benzene (2 ml) and

pyridine (1 drop) were cooled to 0° and treated with oxalyl chloride

(200 Ul dropwise) . Gas was evolved and the solution allowed to warm to
room temperature after which the solvent was removed under vacuum.

Suc-

cessive portions of benzene (2 ml) were added and evaporated and the
residue, in 2 ml warm toluene treated with the above deuterated cholesterol (5 mg) in benzene with three drops pyridine present.

Pyridine

hydrochloride crystallized slowly and the solution left standing at room
temperature overnight.

The solution was diluted with ether and washed

with water (2x), dilute Na2C03 solution (Ix), 1 N HCl (Ix) and water (2x),
dried (MgS04) and evaporated.

The residue was crystallized from acetone

(m.p. 68-71°) and yield = 5 mg (lit. m.p. 78).

The CI mass spectral anal-

ysis showed a mixture of species D^ - D5 with D4 predominating, e.g., Dx
(4%), D2 (137o), D3 (23%), D4 (33%) and D5 (27%).
C.

Preparation of Deuterium Labelled Cholesteryl Palmitate Standard
Cholesteryl palmitate was prepared in an identical manner using

recrystallized palmitic acid (20 mg) dissolved in benzene (2 ml) and
pyridine (1 drop).

The solution was cooled to 0° and treated with oxalyl

chloride (200 ul dropwise) . Gas was evolved and the solution allowed to
warm to room temperature after which the solvent was removed under vacuum.
Successive portions of benzene (2 ml) were added and evaporated and the
residue, in 2 ml warm toluene treated with the above deuterated cholesterol (5 mg) in benzene with three drops pyridine present.

Pyridine

hydrochloride crystallized slowly and the solution left standing at room
temperature overnight.

The solution was diluted with ether and washed

with water (2x), dilute Na2C03 solution (Ix), 1 N HCl (Ix) and water (2x),
dried (MgS04) and evaporated.

The residue was crystallized from acetone

(m.p. 69-71) and yield = 5 mg (lit. m.p. ?).

The mass spectral analysis

showed that the deuterium labelled cholesteryl palmitate contained a
mixture of species D^ - D5 with D4 predominating, e.g., Di (4%), D2 (13%),
D3 (23%), D4 (33%) and D5 (27%).

D.

Mass Spectrometric Analysis of Cholesterol (BDH)
Cholesterol (0.5-2 ]ig in chloroform solutions 0.5-2 yl) were

transferred to a micro-vial (0.5 ml capacity) and the appropriate
deuterated cholesterol standard solutions (chloroform, 1 Ug/yl) was added.
The mixture was then transferred to a probe tip sample holder, evaporated
under vacuum, and admitted to the mass spectrometer using a heatable direct insertion probe.

The CI mass spectrometry of cholesterol was

carried out in the same way as that for the amino acids and fatty acids
except that the spectra of cholesterol were recorded from 100 - 150°C.
The dehydrated peak (MH - H2O)"'" of cholesterol (m/e 369) and that of
internal standard D4 (m/e 373) were monitored and the peak height ratio
of unlabelled to labelled cholesterol was calculated.
E.

Mass Spectrometric Analysis of Blood Cholesterol
(a)

Free Cholesterol

To a reaction vial was added chloroform-methanol (2:1 v/v, 200 yl),
cholesterol-D4 standard (5 Pg in 5 yl chloroform solution) and a 5 yl
blood spot (punched out with 4 mm diameter puncher from 5 yl whole blood
spotted on Guthrie Test filter paper); and the mixture was sonicated
for 5 min.

The filter paper was then removed with tweezers and the

solution was evaporated to dryness with a stream of nitrogen at 80°C.
Hexane (25 yl) was then added to the dry residue and an aliquot of 10 yl
solution was then transferred to a sample holder, evaporated to dryness
under reduced pressure, and admitted through a direct insertion probe for
MS analysis.

The probe tip was then heated slowly in the ion source

region of the mass spectrometer until the free cholesterol spectrum
appeared on the oscilloscope display (80-180°C).

The mass spectrum of

free cholesterol was recorded at 140 - 160°C with a background spectrum
being recorded at 50°C.

The peak height of the unlabelled and the

labelled cholesterol were measured and the peak height ratio for
molecular ion (MH+) , e.g., m/e 487 vs. 391, and for dehydrated peak ion
(MH-H2O), e.g., m/e 369 vs. 373 were monitored.

The blood free choies-

terol levels were also determined by thin-layer chromatography according
to the procedure of Dutta et al.(77),

The purified extract gave the same

ratio between m/e 369 and 373 as did the original extract.
(b)

Total Cholesterol (Free + Bound Cholesterol)

To the remaining hexane solution in the reaction vial, a mixture of
sodium methoxide-methanol (Na/methanol, 0.5 N, 50 ]il) was added and the
vial was capped and the contents heated at 100°C for 15 min.

After

cooling the solvent was evaporated under nitrogen and the dry residue was
redissolved in hexane (25 yl) or chloroform (25 yl) and an aliquot (10 yl)
was transferred to a probe tip holder, evaporated to dryness under reduced pressure, and admitted through a direct insertion probe for MS
analysis.

The probe tip was then heated slowly in the ion source region

of the mass spectrometer until the free cholesterol spectrum appeared on
the oscilloscope display.

The mass spectrum of free cholesterol (after

hydrolysis) was recorded at 140 - 160°C with a background spectrum being
recorded at 50°C.

The peak height of the unlabelled and the labelled

cholesterol were measured and the peak height ratio for molecular ion
(MH+) at m/e 387 vs. 391, and for dehydrated peak ion (MH-H2O) at m/e 369
vs. 373 were calculated.
Free and total cholesterol were calculated as follows:
Total cholesterol, mgX

(
) sample - ( f )
chol-D4
(chol. wt)
(or free cholesterol) = — Y " ;
^
sample volume
( ^ ° • ) calibration
chol-D4

Where (f)
^
(c)

= (Unlabelled (m/e 369)) p^^^ ^^ight ratio of Chol-D
labelled (m/e 373)
Esterified Cholesterol

To a reaction vial were added chloroform-methanol (200 yl; 2:1 v/v),
deuterated cholesteryl palmitate or stearate (5 yg in 5 yl chloroform)
and the dry blood spot (filter paper disc, 4 mm dia. containing 5 yl).
The vial was capped and the contents ultrasonically mixed for 5 min.
The filter paper disc was then removed with tweezers and the solution

concentrateci down to about 25 - 30 ]il with nitrogen at 80°C.

An aliquot

(10 Ul) was transferred to a probe tip sample holder, evaporated under
vacuum and admitted to the mass spectrometer for esterified cholesterol
determinations by solid probe temperature programmed mass spectrometry
at 270 + 10°C.

Esterified cholesterol was calculated according to the

above formula with the exception that "chol-D^^^" should be replaced by
deuterated cholesterol esters; "cholesteryl palmitate" or "stearate".
Values of esterified cholesterol could be also obtained by the differences
between total (procedure E-b) and free cholesterol (procedure E-a).
At 270 + 10°C probe temperature range, the corresponding protonated
cholesterol ester fatty acid peaks were also recorded, e.g., Cie^o "
^20-0

^^^ " 313).

The profile of the esterified cholesterol could

be elucidated by the presence and abundance of the fatty acids in the
mass spectrum.

F,

Mass Spectrometric Analysis of Serum Cholesterol
To a reaction vial was added chloroform-methanol (2:1 v/v, 200 yl),

serum (5-10 Ul) and cholesterol-D4 (5 Ug in 5 ]il chloroform); and the
mixture was sonicated for 5 min. and then evaporated to dryness under
nitrogen at 80°C.

The dry residue was then redissolved in hexane (25 yl).

An aliquot (10 yl) of the mixture was used for free cholesterol
analysis.

This was done by transferring 10 yl solution to a sample

holder, evaporating to dryness under reduced pressure, and admitting the
residue through a direct insertion probe for MS analysis.

The probe tip

was then heated slowly in the ion source region of the mass spectrometer
until the free cholesterol spectrum appeared on the oscilloscope display
(80-180^0.

The mass spectrum of free cholesterol was recorded at 140 -

160°C with a background spectrum being recorded at 50°C.

The peak height

of the unlabelled and the labelled cholesterol were measured and the peak
height ratio for molecular ion (MH+), e.g., m/e 387 vs. 391, and for
dehydrated peak ion (MH-H20)'^, e.g., m/e 369 vs. 373 were monitored.

The

serum free cholesterol levels were calculated after calibration (procedure E-c) .
The remaining portion of hexane solution in the reaction vial was
hydrolyzed with sodium/methanol solution (50 Ul, 0.5 N) at 100°C for
15 min. and analyzed for Total Cholesterol.

An aliquot (10 yl) was trans-

ferred to a probe tip holder, evaporated to dryness under reduced pressure, and admitted through a direct insertion probe for MS analysis.

The

probe tip was heated slowly in the ion source region of the mass
spectrometer until the free cholesterol spectrum appeared on the oscilloscope display.

The mass spectrum of free cholesterol (after hydrolysis)

was recorded at 140 - 160°C with a background spectrum being recorded at
50°C.

The peak height of the unlabelled and the labelled cholesterol

were measured and the peak height ratio for molecular ion (MH+) at m/e 487
vs. 391, and for dehydrated peak ion (MH-H20)'^ at m/e 369 vs. 373 were
calculated.

The serum samples were also analyzed for total cholesterol

levels by a routine Liebermann-Burchard Procedure and by an enzymatic
m e t h o d ^ 7 8 )

and later was conducted at the Wollongong Hospital, Wollongong,

N.S.W., Australia.

G.

Hydrolysis of Cholesterol Esters

Chemical hydrolysis was carried out to free the fatty acid (or
protein) bound cholesterols in estimation of total cholesterol levels in
blood or serum via the route of free cholesterol analysis.
(a)

Acid Hydrolysis with HCl-Methanol:

To a reaction vial was

added cholesteryl palmitate or cholesterol stearate (5 Ug in 5 yl

chloroform) or blood spot (5 yl) extract (chloroform-methanol, 2:1 v/v,
200 yl) and cholesterol-D^ internal standard (5 yg In 5 \il chloroform),
and the solvent was evaporated with nitrogen at 80°C.

The dry residue

was redissolved in 5% HCl/methanol reagent (50-100 yl) and the solution
was heated at 100 - 150°C for 5 - 3 0 min.

An aliquot (10 yl) of the

mixture was then used for free cholesterol analysis by mass spectrometry.
The mass spectrum of free cholesterol (after hydrolysis) was recorded at
140 - 160°C with a background spectrum being recorded at 50°C.

The peak

height of the unlabelled (m/e 369) and the labelled (m/e 373) cholesterol
were measured and the peak height ratios for dehydrated peak ion (MH-H20)'^
at m/e 369 vs. 373 were calculated.

The maximum recovery was determined

which was based on the measurement of peak height ratio at m/e 369 vs.
373.

(b)

Alkaline Hydrolysis with KOH - Ethanol:

To a reaction vial was added cholesteryl palmitate or cholesteryl
stearate (5 yg in 5 yl chloroform) or blood spot (5 yl) extract (chloroform-methanol, 2:1 v/v, 200 yl) and cholesterol-D4 internal standard (5 yg
in 5 yl chloroform) , and the solvent was evaporated with nitrogen at
80°C.

The residue was redissolved in KOH - ethanol reagent (0.5 and 1.0

N, 50-100 yl) and the solution was heated at 100 - 150°C for 5 - 3 0 min.
An aliquot (10 yl) of the mixture was then used for free cholesterol
analysis by M.S. at solid probe temperature 150 + 10°C with a background
spectrum being recorded at 50°C.

The peak height of the unlabelled

(m/e 369) and the labelled (m/e 373) cholesterol were monitored and
measured and the peak height ratios for dehydrated peak ion (MH-H20)+
at m/e 369 vs. 373 were calculated.

The maximum recovery was determined

which was based on the measurement of peak height ratio at m/e 369 vs.
373.

(c) Alkaline Hydrolysis with Na - Methanol
To a reaction vial was added cholesteryl palmitate or cholesteryl
stearate (5 yg in 5 ul chloroform) or blood spot (5 yl) extract (chloroform-methanol, 2:1 v/v, 200 Ul) and cholesterol-D^^ (5 Pg in 5 yl chloroform), and the solvent was evaporated with nitrogen at 80°C.

The residue

was redissolved in 50 - 100 yl sodium methoxide reagent (Na/methanol,
0.5 N) and heated at 100 - 150°C for 5 - 3 0 min.

An aliquot of 10 yl

solution was used for free cholesterol analysis by M.S. at solid probe
temperature 150 + 10 C with a background spectrum being recorded at 50°C.
The peak height of the unlabelled (m/e 369) and the labelled (m/e 373)
cholesterol were monitored and the peak height ratios for dehydrated peak
ion (MH-H2O) at m/e 369 vs. 373 were calculated.

The maximum recovery

was determined which was based on the measurement of peak height ratio
at m/e 369 vs. 373.
The best condition (near 100% recovery) to release bound cholesterol
from its lipoprotein complex and its esters was found to be the method of
heating cholesterol ester samples with Na/MeOH solution (0.5 N) at 100°C
for 15 min.

H.

Quantitation Calibration and Calculation
(a)

Pure Cholesterol

To each reaction vial was added 20 yl chloroform, a fixed amount of
cholesterol-D^ (1.0 yg in 1.0 yl chloroform) and varying amounts of a
reference cholesterol solution (0-2.0 yg, 1 yg/yl chloroform).

After

mixing, an aliquot of 10 yl solution was then transferred to a sample
holder, evaporated to dryness under reduced pressure, and admitted
through a direct insertion probe for MS analysis.
heated slowly to 140 - 160°C

The probe tip was

in the ion source region of the mass

spectrometer until the maximum peak intensity of the free cholesterol
appeared on the oscilloscope display.

Calibration curves of the pure

cholesterol was determined by (1) comparing the dehydrated peak (MH-H20)'^
height at m/e 369 of the unlabelled cholesterol to that of the corresponding labelled standard at m/e 373; and (2) comparing the sum of (M)"^ and
(M-H)"^ peak height (m/e 386 + 385) of the unlabelled cholesterol to that
of the corresponding labelled standard (m/e 390 + 389).

This was done

by a manual method in which five mass spectral scans were recorded on UV
sensitive chart paper and the mean peak height ratios were compiled.

(b)

Blood Cholesterol

To each reaction vial was added 5 yl blood (4 mm discs containing
0-10.0 yg added cholesterol), a fixed amount of choiesterol-D^ (5 yg in
5 yl chloroform) and a mixture of chloroform-methanol (2:1 v/v, 200 yl).
The solution was sonicated for 5 min. and an aliquot of 10 yl was transferred to a sample holder, evaporated to dryness under reduced pressure,
and admitted through a direct insertion probe for MS analysis.

The

probe tip was heated slowly to 140-160°C in the ion source region of the
mass spectrometer until the maximum peak intensity of the free cholesterol appeared on the oscilloscope display.

Calibration curves of the

blood cholesterol was determined by comparing the dehydrated peak (MHH20)+ height at m/e 369 of the unlabelled cholesterol to that of the
corresponding labelled standard at m/e 373.

This was done by a manual

method in which 5 mass spectral scans were recorded on UV sensitive
chart paper and the mean peak height ratios were compiled.

(c)

Blood Cholesterol Ester

To each reaction vial was added 5 yl blood (4 mm discs containing
0-9.0 yg added cholesterol palmitate), a fixed amount of cholesterol

palmitate-D^ (5 yg/5 yl chloroform) and a mixture of chloroform-methanol
(2:1 v/v, 200 yl).

The solution was sonicated for 5 min. and an aliquot

of 10 yl was transferred to a sample holder, evaporated to dryness under
reduced pressure, and admitted through a direct insertion probe for MS
analysis.

The probe tip was heated slowly to 260 - 280°C in the ion

source region of the mass spectrometer until the maximum peak intensity
of the dehydrated cholesterol peak (m/e 369) appeared on the oscilloscope
display.

Calibration curves of the blood cholesterol ester was deter-

mined by comparing the dehydrated peak (MH-H20)"^ height at m/e 369 of the
unlabelled cholesterol ester to that of the corresponding labelled
standard at m/e 373.

This was done by a manual method in which 5 mass

spectral scans were recorded on UV sensitive chart paper and the mean
peak height ratios were compiled.

IV.

Quantitative Analysis of Estrogens
Estrogen, e.g., estrone, estradiol and estriol, were obtained from

ICN Biochemicals (Irvine, USA).

A.

Preparation of Deuterium Labelled Estrogens Standard
The deuterated estrogens were prepared using a method of Fried and

Edwards^^^).

Estrone, estradiol or estriol (20 mg) in methanol-OD (5 ml)

with D2SO4 (1 drop in 0.5 ml D2O) was refluxed for 5 days.

After cooling,

the reaction mixture was diluted with ether, washed with dilute NaHC03
(2x) and water (2x), dried (MgS04) and evaporated.

The product was re-

crystallized (ether-hexane) m.p. 172 - 174 . The mass spectral (CI)
analysis of the labelled estrogens showed a mixture of species D^, Dj^ and
D2 with D2 predominating (50% D2).

B.

Analysis of Pure Estrogens
The CI mass spectra of estrone (m/e 271), estradiol (m/e 273) and

estriol (m/e 289) were recorded at solid probe temperatures of 100 200°C.

The dehydrated peak (MH-H20)'^ of the corresponding estrogens

(m/e 253 for estrone, m/e 255 for estradiol and m/e 271 for estriol) and
their ion intensity in term of peak height were calculated.

A calibra-

tion curve (peak height ratio vs. concentration) for estriol (m/e 289)
with internal standard estriol-D2 (m/e 291) was determined by using a
fixed amount of estriol-D2 (4 Ug, 1 yg/5 yl ethanol) and a concentration
range of estriol (0-8 Ug, 1 yg/5 yl ethanol).

C.

Analysis of Urinary Estriol
Urine (100 yl) was transferred to screw cap reaction vial and HCl

(200 yl, 2N) was added.
at 120°C for 15 min.

The contents were mixed and the tube was heated

After hydrolysis, the tube was cooled and the

deuterated estriol (D2) standard (2 yg, in 10 yl ethanol) was added.
The sterols were then extracted with diethyl ether (600 yl) using a
Vortex mixing for 2 min. followed by separation of the layers.

The

diethyl ether layer was then transferred into a small vial and evaporated
to dryness under nitrogen at 80°C.

The dry residue was redissolved in

ethanol (25 yl), and an aliquot of 10 yl was used for mass spectrometric analysis.

The m/e values of unlabelled estriol and labelled

estriol-D2 at 289 and 291 and their peak height ratio (m/e 289 vs.
m/e 291) were monitored.

The value of estriol levels in urine samples

was obtained using a similar formula described for amino and fatty acids
analyses.

Urine samples were also analyzed for estrogens by Technicon

Automated Estrogen Assay with fluroimetric and point

method(82)

and the

assay was conducted at Royal Prince Alfred Hospital Endocrine Laboratory,
Camperdon, Sydney.
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